US 6,515,155 B1Grant
Substituted group 4 metal complexes, catalysts and olefin polymerization process
Issue Date:2003-02-04
•12 Claims
•3 Drawing Sheets
Abstract
Group 4 metal complexes of the constrained geometry type, catalysts derived therefrom and polymerization processes using the same, characterized by a nitrogen containing aliphatic or cycloaliphatic moiety that is substituted with one or more aryl groups, an aryl-substituted silane bridging group, or one or more Group 14 organometalloid substituted hydrocarbyl substituents on the metal.
Metadata
Assignee
- Dow Global TEchnologies Inc.
Inventors
- Jerzy Klosin
- Peter N. Nickias
- William J. Kruper, Jr.
- Gordon R. Roof
- Jorge Soto
Application Information
Application Number:US 09/715,380
Filing Date:2000-11-17
Priority Date:1999-12-10
Art Unit:7
Classifications
IPC:
C07F 710
Field of Search:
526943526160526161526163526164526170556 11556 52
Patent Drawings (3 sheets)
Description
CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] This application claims benefit of priority from provisional applications 60/170,178, 60/170,177, and 60/170,175, all filed on Dec. 10, 1999.
FIELD OF THE INVENTION
[0003] This invention relates to a class of metal complexes, the ligands used to prepare these metal complexes, polymerization catalysts derived therefrom, and the resulting polymerization processes using the same. More particularly, such metal complexes are characterized by a nitrogen containing aliphatic or cycloaliphatic moiety that is substituted with one or more aryl groups, an aryl-substituted silane bridging group, or one or more Group 14 organometalloid substituents on the metal.
BACKGROUND
[0004] EP-A-923,589, which is equivalent to WO98/06727, published Feb. 19, 1998, disclosed Group 4 metal complexes containing a heteroatom substituent at the 3-position of the cyclopentadienyl, especially indenyl, ligand groups. Particular heteroatom containing substituents included dihydrocarbylamino substituents including dimethylamino, diethylamino, methylethylamino, methylphenylamino, dipropylamino, dibutylamino, piperidinyl, morpholinyl, pyrrolidinyl, hexahydro-1H-azepin-1-yl, hexahydro-1(2H)-azocinyl, octahydro-1H-azonin-1-yl, and octahydro-1(2H)-azecinyl.
[0005] EP-A-577,581 discloses unsymmetrical bis-Cp metallocenes containing a fluorenyl ligand with heteroatom substituents. E. Barsties; S. Schaible; M.-H. Prosenc; U. Rief; W. Roll; O. Weyland; B. Dorerer; H. -H. Brintzinger J. Organometallic Chem. 1996, 520, 63-68, and H. Plenio; D. Birth J. Organometallic Chem. 1996, 519, 269-272 disclose systems in which the cyclopentadienyl ring of the indenyl is substituted with a dimethylamino group in non-bridged and Si-bridged bis-indenyl complexes useful for the formation of isotactic polypropylene and polyethylene.
[0006] Disclosure of random heteroatom substitution in mono-Cp metallocenes is found in EP-A416,815, WO 95/07942, WO 96/13529, and USP's 5,096,867 and 5,621,126. Specific heteroatom substitution of the 3- and 2-position of indenyl complexes of group 4 metals was disclosed in WO98/06727 and WO/98/06728 respectively.
[0007] Despite the advance in the art, particular higher use temperature, obtained by such prior art metal complexes as were disclosed in the foregoing reference, there remains a desire for improved metal complexes capable of even further increase in use temperature that are still capable of forming catalyst compositions useful in producing polymers having high molecular weights and, for ethylene/higher α-olefin copolymers, high incorporation of comonomer. The subject compositions of this invention show unexpected improvement in these desirable features.
SUMMARY OF THE INVENTION
[0008] According to the present invention there are provided metal complexes corresponding to the formula:
[0009] where M is a Group 4 metal that is in the +2, +3 or +4 formal oxidation state;
[0010] RAindependently each occurrence is hydrogen, or a hydrocarbyl, halohydrocarbyl, hydrocarbyloxyhydrocarbyl, dihydrocarbylaminohydrocarbyl, dihydrocarbylamino, hydrocarbyloxy, hydrocarbylsilyl, or trihydrocarbylsilylhydrocarbyl group of from 1 to 80 atoms, not counting hydrogen, or further optionally, two or more RAgroups from the same or different metal complexes or RAand RB′ from the same or different metal complexes may be covalently linked together;
[0011] RB′ independently each occurrence is hydrogen, or a hydrocarbyl, halohydrocarbyl, hydrocarbyloxyhydrocarbyl, dihydrocarbylaminohydrocarbyl, dihydrocarbylamino, hydrocarbyloxy, hydrocarbylsilyl, or trihydrocarbylsilylhydrocarbyl group of from 1 to 80 atoms, not counting hydrogen, and optionally, two or more RB′ groups from different metal complex or RB′ and an RAfrom the same or a different metal complex may be covalently linked together;
[0012] Z is a divalent moiety, bound to M via a covalent or coordinate/covalent bond, comprising boron, or a member of Group 14 of the Periodic Table of the Elements, and also comprising nitrogen, phosphorus, sulfur or oxygen;
[0013] X′ is an anionic or dianionic ligand group having up to 60 atoms exclusive of the class of ligands that are cyclic, delocalized, r-bound ligand groups;
[0014] X′ independently each occurrence is a neutral ligand having up to 40 atoms;
[0015] p is zero, 1 or 2, and is two less than the formal oxidation state of M when X is an anionic ligand, and when X is a dianionic ligand group, p is 1; and
[0016] q is zero, 1 or 2;
[0017] with the proviso that one or more of the following conditions A), B) or C), is true:
[0018] A) RB′ corresponds to the formula N(RB)2, wherein RBeach occurrence is aralkyl, or two RBgroups together form a divalent hydrocarbon moiety or a halo- or silyl-substituted derivative thereof, said group containing from 4 to 40 atoms not counting hydrogen, and comprising at least one aromatic substituent, AR;
[0019] B) Z is (RD)2Si—Y—, wherein RDindependently each occurrence is C6-20aryl or two RDgroups together are C6-20arylene; and
[0020] Y is bonded to M and is selected from the group consisting of —O—, —S—, —NRE—, and —PRE—; wherein, REindependently each occurrence is hydrogen, or a member selected from hydrocarbyl, hydrocarbyloxy, silyl, halogenated alkyl, halogenated aryl, and combinations thereof, said REhaving up to 20 nonhydrogen atoms; or
[0021] C) X in at least one occurrence is selected from the group consisting of tri(hydrocarbyl)silylhydrocarbyl, tri(hydrocarbyl)germylhydrocarbyl, and mixtures thereof, or two X groups together are a divalent ligand group of the formula (ER′2)x′ wherein E is silicon, germanium or carbon, but in at least one occurrence is silicon or germanium, and R′ independently each occurrence is hydrogen or a group selected from silyl, hydrocarbyl, hydrocarbyloxy and combinations thereof, said R′ having up to 30 carbon or silicon atoms, and x′ is an integer from 1 to 8.
[0022] The above complexes may exist as isolated crystals optionally in pure form or as a mixture with other complexes, in the form of a solvated adduct, optionally in a solvent, especially an organic liquid, in the form of a dimer or chelated derivative thereof, wherein the chelating agent is an organic material, preferably a Lewis base, especially a dihydrocarbylether, cyclic aliphatic ether, trihydrocarbylamine, trihydrocarbylphosphine, or halogenated derivative thereof, or as a polymeric or crosslinked polymeric product, wherein one or more RAgroups are polymerized with one another or copolymerized with an ethylenically unsaturated comomomer.
[0023] Also, according to the present invention, there is provided a catalyst composition, useful, inter alia, for the polymerization of addition polymerizable monomers, comprising the following components or the reaction product thereof:
[0024] (A) one or more metal complexes of formula (I); and
[0025] (B) an activating cocatalyst, wherein the molar ratio of (A) to (B) is from 1 :10,000 to 100:1.
[0026] Another embodiment of this invention is the foregoing catalyst composition wherein the metal complex is in the form of a radical cation.
[0027] Further according to the present invention there is provided a polymerization process comprising contacting one or more addition polymerizable monomers under polymerization conditions with one of the aforementioned catalyst compositions.
[0028] A preferred process of this invention is a high temperature solution polymerization process comprising contacting one or more addition polymerizable monomers under polymerization conditions with one of the aforementioned catalyst systems at a temperature from 50° C. to 250° C., preferably from 150° C. to 250° C., most preferably from 175° C. to 220° C. Within the scope of this invention are the polymeric products produced by the aforementioned processes.
[0029] This invention also includes the precursor of the delocalized electron containing, cyclic moiety of the metal complex of formula (I), said precursor corresponding to the formula:
[0030] wherein, Y′ is —ORC, —SRC, —NRCRE, —PRCRE;
[0031] RAand REare as previously defined;
[0032] RB′ independently each occurrence is hydrogen, or a hydrocarbyl, halohydrocarbyl, hydrocarbyloxyhydrocarbyl, dihydrocarbylaminohydrocarbyl, dihydrocarbylamino, hydrocarbyloxy, hydrocarbylsilyl, or trihydrocarbylsilylhydrocarbyl group of from 1 to 80 atoms, not counting hydrogen, and optionally, two or more RB′ groups from different metal complex or RB′ and an RAfrom the same or a different metal complex may be covalently linked together;
[0033] Z* is SiRG2, CRG2, SiRG2SiRG2, CRG2CRG2, CRG═CRG, CRG2SiRG2, CRG2SiRG2CRG2, SiRG2CRG2SiRG2, CRG2CRG2SiRG2, CRG2CRG2CRG2, BRG2, or GeRG2;
[0034] wherein each RCgroup is hydrogen, an alkali metal cation, or a magnesium halide cation, or both RCgroups together are an alkaline earth metal dication; and
[0035] RGindependently each occurrence is hydrogen, or a member selected from hydrocarbyl, hydrocarbyloxy, silyl, halogenated alkyl, halogenated aryl, and combinations thereof, said RGhaving up to 20 nonhydrogen atoms, and optionally two RGgroups may be joined together,
[0036] with the proviso that one or both of the following conditions are true:
[0037] 1) RB′ corresponds to the formula N(RB)2, wherein RBeach occurrence is aralkyl, or two RBgroups together form a divalent hydrocarbon moiety or a halo- or silyl-substituted derivative thereof, said group containing from 4 to 40 atoms not counting hydrogen, and comprising at least one aromatic substituent, AR;
[0038] 2) Z* is —(RD)2Si—, wherein RDindependently each occurrence is C6-20aryl or two RDgroups together are C6-20arylene.
[0039] It is to be understood that the foregoing formula (II) depicts one of several equivalent interannular, double bond isomers, and that all such isomeric structures are intended to be included by formula (II).
[0040] The final embodiment of the invention is the use of one of the foregoing compounds of formula (II) in a synthesis to produce a Group 4 metal complex of formula (I).
[0041] The present catalysts and processes are especially suited for use in the production of high molecular weight polymers of olefin monomers, over a wide range of polymerization conditions, and especially at elevated temperatures, with exceptionally high catalyst efficiencies. They are especially useful for the solution polymerization of ethylene homopolymers, copolymers of ethylene with an α-olefin other than ethylene (ethylene/α-olefin copolymers), and ethylene/propylene/diene interpolymers (EPDM polymers) wherein the diene is ethylidenenorbomene, 1,4-hexadiene or similar nonconjugated diene. The use of elevated temperatures dramatically increases the productivity of such processes due to the fact that increased polymer solubility at elevated temperatures allows the use of increased conversions (higher concentration of polymer product) without exceeding solution viscosity limitations of the polymerization equipment as well as reduced energy costs needed to devolatilize the reaction product. In the preparation particularly of copolymers of ethylene and at least one α-olefin comonomer, the present catalyst compositions incorporate relatively large quantities of non-ethylene comomomer compared to catalysts comprising a conventional metal. In particular, ethylene/1-octene copolymers having reduced density due to increased incorporation of 1-octene therein, may be made using the present catalyst compositions.
[0042] The metal complexes of this invention may also be supported on a support material and used in olefin polymerization processes in a slurry or in the gas phase. Additionally, those complexes wherein RAis ethylenically unsaturated may be used to form polymeric reaction products via polymerization of copolymerization of such ethylenic unsaturation in the RAmoiety. Such products may be employed in a slurry or gas phase polymerization without need for an additional support material. Such a polymeric catalyst may be formed by prepolymerization of the functionalized metal complex, optionally with one or more ethylenically unsaturated monomers, in situ in a polymerization reactor or in a separate reactor with recovery of the prepolymerized catalyst prior to the primary polymerization process.
BRIEF DESCRIPTION OF THE DRAWINGS
[0043] FIG. 1 shows the single crystal structure derived by X-ray analysis (ORTEP) of (N-(1,1-dimethyletbyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)titanium dimethyl (Example 2).
[0044] FIG. 2 shows the single crystal structure derived by X-ray analysis (ORTEP) of (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)titanium dimethyl (Example 4).
[0045] FIG. 3 shows the single crystal structure derived by X-ray analysis (ORTEP) of (N-(1,1dimethylethyl)-1,1-di(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-[(dimethylsilylene)bis(methylene)] titanium (Example 18).
[0046] FIG. 4 shows the single crystal structure derived by X-ray analysis (ORTEP) of (N-(1,1-dimethylethyl)-1,1-di(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl) (Example 19).
[0047] FIG. 5 shows the single crystal structure derived by X-ray analysis (ORTEP) of [1(1,2,3,3a,11b-η)-1H-cyclopenta[l]phenanthren-2-yl]-N-(1,1-dimethylethyl)-1,1-dimethylsilanaminato(2-)-N-]-[bis(trimethylsilymethyl)] titanium (Example 25).
DETAILED DESCRIPTION
[0048] All reference to the Periodic Table of the Elements herein shall refer to the Periodic Table of the Elements, published and copyrighted by CRC Press, Inc., 1997. Also, any reference to a Group or Groups shall be to the Group or Groups as reflected in this Periodic Table of the Elements using the IUPAC system for numbering groups. As used herein the term “comprising” is not intended to exclude any additional component, additive or step. For purposes of United States patent practice, the contents of any patent, patent application or publication referenced herein are hereby incorporated by reference in their entirety, especially with respect to the disclosure of synthetic techniques and general knowledge in the art.
[0049] The foregoing metal complexes are preferably subdivided into preferred embodiments, A) B) and C), as follows.
[0050] A) Metal complexes corresponding to the formula:
[0051] where M is a Group 4 metal that is in the +2, +3 or +4 formal oxidation state;
[0052] RAindependently each occurrence is hydrogen, or a hydrocarbyl, halohydrocarbyl, hydrocarbyloxyhydrocarbyl, dihydrocarbylaminohydrocarbyl, dihydrocarbylamino, hydrocarbyloxy, hydrocarbylsilyl, or trihydrocarbylsilylhydrocarbyl group of from 1 to 80 atoms, not counting hydrogen, or further optionally, two or more RAgroups from the same or different metal complex may be covalently linked together;
[0053] RBindependently each occurrence is aralkyl, or two RBgroups together form a divalent hydrocarbon moiety or a halo- or silyl-substituted derivative thereof, said group containing from 4 to 40 atoms not counting hydrogen, and comprising at least one aromatic substituent, AR;
[0054] Z is a divalent moiety, bound to M via a covalent or coordinate/covalent bond, comprising boron, or a member of Group 14 of the Periodic Table of the Elements, and also comprising nitrogen, phosphorus, sulfur or oxygen;
[0055] X is an anionic or dianionic ligand group having up to 60 atoms exclusive of the class of ligands that are cyclic, delocalized, π-bound ligand groups;
[0056] X′ independently each occurrence is a neutral ligand having up to 40 atoms;
[0057] p is zero, 1 or 2, and is two less than the formal oxidation state of M when X is an anionic ligand, and when X is a dianionic ligand group, p is 1; and
[0058] q is zero, 1 or 2.
[0059] B) Metal complexes corresponding to the formula:
[0060] where M is a Group 4 metal that is in the +2, +3 or +4 formal oxidation state;
[0061] RAindependently each occurrence is hydrogen, or a hydrocarbyl, halohydrocarbyl, hydrocarbyloxyhydrocarbyl, dihydrocarbylaminohydrocarbyl, dihydrocarbylamino, hydrocarbylsilyl, or trihydrocarbylsilylhydrocarbyl group of from 1 to 80 atoms, not counting hydrogen, or further optionally, two or more RAgroups from the same or different metal complex are covalently bonded together;
[0062] Z* is SiRD2;
[0063] RDindependently each occurrence is C6-20aryl or two RDgroups together are C6-20arylene;
[0064] Y is —O—, —S—, —NRE—, —PRE—; and
[0065] REindependently each occurrence is hydrogen, or a member selected from hydrocarbyl, hydrocarbyloxy, silyl, halogenated alkyl, halogenated aryl, and combinations thereof, said REhaving up to 20 nonhydrogen atoms;
[0066] X is an anionic or dianionic ligand group having up to 60 atoms exclusive of the class of ligands that are cyclic, delocalized, π-bound ligand groups;
[0067] X′ independently each occurrence is a neutral ligand having up to 40 atoms;
[0068] p is zero, 1 or 2, and is two less than the formal oxidation state of M when X is an anionic ligand or absent, and when X is a dianionic ligand group, p is 1; and
[0069] q is zero, 1 or 2.
[0070] C) Metal complexes corresponding to the formula:
[0071] where M is a Group 4 metal that is in the +3 or +4 formal oxidation state;
[0072] RAindependently each occurrence is hydrogen, or a hydrocarbyl, halohydrocarbyl, hydrocarbyloxyhydrocarbyl, dihydrocarbylaminohydrocarbyl, dihydrocarbylamino, hydrocarbylsilyl, or trihydrocarbylsilylhydrocarbyl group of from 1 to 80 atoms, not counting hydrogen, or further optionally, two or more RAgroups from the same or different metal complex may be covalently linked together;
[0073] Z is a divalent moiety, bound to M via a covalent or coordinate/covalent bond, comprising boron, or a member of Group 14 of the Periodic Table of the Elements, and also comprising nitrogen, phosphorus, sulfur or oxygen;
[0074] X, is an anionic ligand group, with the proviso, that in at least one occurrence X is trialkylsilylmethyl, having from 1 to 4 carbons in each alkyl group, or two X groups together are (dimethylsilylene)bis(methylene);
[0075] X′ independently each occurrence is a neutral Lewis base compound coordinated to the metal complex and having up to 40 atoms;
[0076] p is 1 or 2; and
[0077] q is zero, 1 or 2.
[0078] In all of the foregoing preferred embodiments A), B) and C), N(RB)2, is preferably dibenzylamino or two RBgroups together with the nitrogen atom form a cycloaliphatic group, and at least one of the ARgroups comprising RBis a single or multiple ring, aromatic group. More preferably, in the embodiment wherein two RBgroups together with the nitrogen atom form a cycloaliphatic group, a single ARgroup, which is a C6-20aromatic hydrocarbon group, is fused to the cycloaliphatic group. Most preferably, —N(RB)2is in the form of a multiple ring, fused, azacyclic group. Examples of the foregoing, —N(RB)2groups include: 1,3-dihydro-2H-isoindol-2-yl, 1,2,3,4-tetrahydro-2H-isoquinoline-2-yl, 1,3-dihydro-2H-benzo[f]isoindol-2-yl, 1,3-dihydro-2H-benzo[e]isoindol-2-yl, 1,2,3,4-tetrahydro-2H-benzo[g]isoquinoline-2-yl, 1,2,3,4-tetrahydro-2H-benzo[f]isoquinoline-2-yl, 1,2,3,4-tetrahydro-2H-benzo[h]isoquinoline-2-yl, 1H-benzo[de]isoquinolin-2(3H)-yl, and dibenzylamino groups, corresponding to the following formulas:
[0079] Also in the foregoing preferred embodiments A), B), and C) of the invention, —Z*— is preferably Si(RG)2-, where RG, each occurrence, is phenyl, tolyl, benzyl, n-butylphenyl, naphthyl, or two RGgroups together are:
[0080] Most preferably, RGeach occurrence is phenyl, 4-methylphenyl, or 4-n-butylphenyl.
[0081] A preferred Group 4 metal for all of the present metal complexes is titanium.
[0082] Finally, for the foregoing preferred embodiments A) and B), preferred X groups are chloro, methyl, trimethylsilylmethyl, or two X groups together are (dimethylsilylene)bis-(methylene), most preferably trimethylsilylmethyl, or two X groups together are (dimethylsilylene)bis(methylene). In the embodiments wherein X is trimethylsilylmethyl the complexes possess improved catalytic activity. In the embodiments wherein two X groups together are (dimethylsilylene)bis(methylene) the metal complexes additionally are particularly stable (robust) under typical storage and use conditions.
[0083] Preferred RAgroups in embodiments A), B) and C) (other than the —NRBgroups previously disclosed at the 3 position) are hydrogen, or an alkyl, aryl or aralkyl group of up to 10 carbons.
[0084] Preferably in all embodiments of the invention, Y is —NRE— where REis C1-6alkyl or cycloalkyl, preferably isopropyl, cyclohexyl, or t-butyl.
[0085] Preferred X′ groups in all of the foregoing embodiments of the invention are carbon monoxide; phosphines, especially trimethylphosphine, triethylphosphine, triphenylphosphine and bis(1,2-dimethylphosphino)ethane; P(ORK)3, wherein RK, independently each occurrence, is hydrocarbyl, silyl or silylhydrocarbyl; ethers, especially tetrahydrofuran; amines, especially pyridine, bipyridine, tetramethylethylenediamine (TMEDA), or triethylamine; olefins; and conjugated dienes having from 4 to 40 carbon atoms. Complexes including the latter X′ groups, especially terminally hydrocarbyl substituted-1,3-butadienes, include those wherein the metal is in the +2 formal oxidation state.
[0086] In the foregoing preferred embodiments A) and B), when p is 2, q is zero, M is in the+3 or +4 formal oxidation state, and X is independently each occurrence preferably is chloride, methyl, benzyl, trimethylsilylmethyl, allyl, pyrollyl or two X groups together are 1,4-butane-diyl, 2 butene-1,4-diyl, 2,3-dimethyl-2-butene-1,4-diyl, 2-methyl-2-butene-1,4-diyl, xylyldiyl, or (dimethylsilylene)bis(methylene).
[0087] In preferred embodiments A) and B), when p is 1, q is zero, M is in the +3 formal oxidation state, and X is preferably, 2-(N,N-dimethyl)aminobenzyl, 2-(N,N-dimethylaminomethyl)phenyl, allyl, or methallyl.
[0088] In preferred embodiments A and B), when p is 0, q is 1, M is in the +2 formal oxidation state, and X′ is 1,4-diphenyl-1,3-butadiene, 1,3-pentadiene or 2,4-hexadiene.
[0089] Highly preferred complexes according to embodiment A) correspond to the formulas:
[0090] where RH, is methyl, phenyl, tolyl or n-butylphenyl;
[0091] Rlis chloro, methyl, benzyl, trimethylsilylmethyl or two R1groups together are (dimethylsilylene)bis(methylene); and
[0092] RJis allyl, 2-(dimethylamino)benzyl, 1,4-pentadiene or 1,4-diphenyl-1,3-butadiene.
[0093] In the complexes of the formula IA 1′ and IA2′ the titanium metal is formally in the +3 oxidation state when RJis allyl or 2-(dimethylamino)benzyl, and in the +2 oxidation state when RJis 1,4-pentadiene or 1,4-diphenyl-1,3-butadiene.
[0094] For preferred embodiment A), illustrative metal complexes according to the present invention include:
[0095] dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0096] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0097] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0098] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0099] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0100] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0101] dichloro(N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0102] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1-yl)silanaminato-(2-)-N-)-titaniumdimethyl;
[0103] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0104] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0105] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0106] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0107] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0108] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0109] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0110] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0111] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0112] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0113] dichloro(N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0114] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0115] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0116] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0117] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0118] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0119] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0120] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0121] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0122] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0123] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0124] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0125] dichloro(N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0126] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0127] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0128] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0129] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzy;
[0130] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0131] dichloro(N-(1,1-dimethylethyl) 1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)titanium;
[0132] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0133] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0134] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2-(1H)-isoquinolinyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0135] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N -dimethylamino)benzyl;
[0136] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0137] dichloro(N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl-(1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0138] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl-(1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0139] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inde-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0140] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl-(1H-inde-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0141] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl-(1H-inde-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0142] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolin 1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0143] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0144] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0145] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0146] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0147] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0148] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0149] dichloro(N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0150] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0151] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0152] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0153] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0154] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0155] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0156] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0157] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0158] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0159] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0160] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0161] dichloro(N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0162] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0163] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0164] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0165] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0166] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0167] dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0168] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0169] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0170] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0171] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0172] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0173] dichloro(N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0174] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0175] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0176] N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0177] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0178] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0179] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0180] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0181] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethysilylmethyl;
[0182] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0183] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0184] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0185] dichloro(N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0186] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0187] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethysilylmethyl bis(trimethysilylmethyl;
[0188] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0189] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0190] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0191] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0192] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0193] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethysilylmethyl;
[0194] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0195] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0196] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0197] dichloro(N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0198] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0199] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethysilylmethyl bis(trimethysilylmethyl;
[0200] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0201] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0202] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0203] dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0204] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0205] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0206] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0207] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0208] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0209] dichloro(N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0210] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0211] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0212] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0213] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0214] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0215] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0216] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0217] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0218] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0219] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0220] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0221] dichloro(N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0222] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0223] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0224] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0225] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0226] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0227] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0228] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0229] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0230] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0231] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0232] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0233] dichloro(N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0234] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0235] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0236] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0237] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0238] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0239] dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium;
[0240] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium dimethyl;
[0241] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0242] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0243] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0244] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0245] dichloro(N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium;
[0246] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium dimethyl;
[0247] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0248] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0249] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0250] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0251] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium;
[0252] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium dimethyl;
[0253] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium bis(trimethysilylmethyl;
[0254] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0255] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0256] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0257] dichloro(N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium;
[0258] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium dimethyl;
[0259] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0260] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0261] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0262] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0263] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-I1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium;
[0264] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-I1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium dimethyl;
[0265] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-I1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium bis(trimethysilylmethyl;
[0266] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-I1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0267] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0268] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0269] dichloro(N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium;
[0270] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a, 7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium dimethyl;
[0271] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0272] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0273] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0274] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanamiento-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0275] dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0276] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0277] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0278] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0279] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0280] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0281] dichloro(N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0282] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0283] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0284] N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0285] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0286] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0287] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0288] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0289] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0290] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0291] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0292] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0293] dichloro(N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0294] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0295] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0296] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0297] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl; and
[0298] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene.
[0299] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0300] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0301] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0302] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0303] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0304] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0305] dichloro(N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0306] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0307] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0308] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0309] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl; and
[0310] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene.
[0311] For preferred embodiment B), illustrative metal complexes include those corresponding to the following formulas:
[0312] where RFis phenyl, tolyl or butylphenyl, especially 4-tolyl or 4-n-butylphenyl;
[0313] R1is methyl or trimethylsilylmethyl or two R1groups together are (dimethylsilylene)bis(methylene); and
[0314] RJis allyl, 2-(dimethylamino)benzyl, 1,4-pentadiene or 1,4-diphenyl-1,3-butadiene.
[0315] In the complexes of the formula IB 1′, IB2′, IB3′, IB4′, IB5′, IB6′, IB7′, and IB8′, the titanium metal is formally in the +3 oxidation state when RJis allyl or 2-(dimethylamino)benzyl, and in the +2 oxidation state when RJis 1,4-pentadiene or 1,4-diphenyl-1,3-butadiene.
[0316] Illustrative metal complexes according to embodiment B) of the present invention include the following complexes (which may duplicate in part complexes within embodiment A):
[0317] dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titanium;
[0318] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)N-)-titanium dimethyl;
[0319] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)N-)-titanium bis(trimethylsilylmethyl);
[0320] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)N-)-titanium (dimethylsilylene)bis(methylene);
[0321] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0322] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0323] dichloro(N-(cyclohexyl)-1,1-diphenyl-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2)-N-)-titanium;
[0324] (N-(cyclohexyl)-1,1-diphenyl-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titaniumdimethyl;
[0325] (N-(cyclohexyl)-1,1-diphenyl-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0326] (N-(cyclohexyl)-1,1-diphenyl-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0327] (N-(cyclohexyl)-1,1-diphenyl-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)titanium (III) 2-(N,N-dimethylamino)benzyl;
[0328] (N-(cyclohexyl)-1,1-diphenyl-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)titanium (II) 1,4-diphenyl-1,3-butadiene;
[0329] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titanium;
[0330] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titanium dimethyl;
[0331] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0332] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-(dimethylsilylene)bis(methylene);
[0333] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0334] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0335] dichloro(N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titanium;
[0336] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato(2-)-N-)-titaniumdimethyl
[0337] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0338] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0339] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0340] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0341] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titanium;
[0342] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titanium dimethyl;
[0343] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0344] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0345] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2(III)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0346] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0347] dichloro(N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titanium;
[0348] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titaniumdimethyl;
[0349] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0350] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0351] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0352] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0353] dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0354] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0355] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0356] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7aη)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0357] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0358] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0359] dichloro(N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0360] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titaniumdimethyl;
[0361] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0362] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0363] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 2-(N,N-dimethylamino)benzyl;
[0364] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0365] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0366] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0367] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0368] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium 1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0369] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0370] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0371] dichloro(N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0372] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0373] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0374] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0375] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0376] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0377] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0378] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0379] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0380] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0381] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0382] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0383] dichloro(N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0384] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0385] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0386] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0387] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0388] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0389] dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0390] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0391] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0392] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0393] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0394] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0395] dichloro(N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0396] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titaniumdimethyl;
[0397] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0398] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0399] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0400] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0401] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0402] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0403] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0404] N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0405] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0406] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0407] dichloro(N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0408] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0409] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0410] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0411] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0412] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0413] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0414] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0415] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0416] N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0417] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0418] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0419] dichloro(N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0420] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0421] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0422] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0423] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0424] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0425] dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0426] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0427] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0428] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0429] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0430] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0431] dichloro(N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0432] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0433] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0434] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0435] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0436] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0437] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0438] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0439] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0440] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0441] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0442] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0443] dichloro(N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0444] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0445] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0446] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0447] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0448] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0449] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0450] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0451] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0452] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0453] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0454] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0455] dichloro(N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0456] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0457] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0458] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0459] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0460] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0461] dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-(1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0462] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0463] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0464] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0465] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0466] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0467] dichloro(N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0468] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titaniumdimethyl;
[0469] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0470] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0471] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0472] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0473] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0474] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0475] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0476] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0477] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0478] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0479] dichloro(N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0480] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0481] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0482] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0483] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0484] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0485] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0486] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0487] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0488] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0489] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0490] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0491] dichloro(N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0492] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0493] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0494] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0495] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0496] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0497] dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0498] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0499] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0500] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0501] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl))-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0502] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0503] dichloro(N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0504] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0505] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0506] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0507] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0508] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0509] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0510] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0511] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0512] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethylsilylene)bis(methylene);
[0513] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0514] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0515] dichloro(N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0516] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0517] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0518] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0519] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0520] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0521] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0522] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0523] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0524] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethylsilylene)bis(methylene);
[0525] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0526] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0527] dichloro(N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0528] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0529] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0530] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0531] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0532] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0533] dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0534] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0535] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0536] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethylsilylene)bis(methylene);
[0537] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-methylamino)benzyl;
[0538] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0539] dichloro(N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0540] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-ηn)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0541] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0542] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0543] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0544] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0545] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0546] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0547] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl;
[0548] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0549] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-methylamino)benzyl;
[0550] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0551] dichloro(N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0552] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0553] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl bis(trimethylsilylmethyl;
[0554] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0555] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0556] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0557] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0558] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0559] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl;
[0560] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0561] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0562] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0563] dichloro(N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0564] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0565] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-1 l)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl bis(trimethylsilylmethyl;
[0566] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0567] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0568] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0569] dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0570] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0571] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0572] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0573] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0574] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0575] dichloro(N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0576] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0577] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0578] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0579] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0580] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0581] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0582] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0583] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0584] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0585] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0586] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0587] dichloro(N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0588] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0589] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0590] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0591] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0592] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0593] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0594] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0595] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0596] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0597] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0598] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0599] dichloro(N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0600] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0601] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0602] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0603] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0604] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isonidol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0605] dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0606] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0607] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0608] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0609] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0610] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0611] dichloro(N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0612] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0613] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0614] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0615] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0616] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0617] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0618] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0619] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl;
[0620] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0621] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0622] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0623] dichloro(N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0624] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0625] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0626] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0627] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0628] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0629] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0630] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0631] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl;
[0632] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0633] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0634] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0635] dichloro(N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0636] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0637] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0638] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0639] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0640] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0641] dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0642] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2)-N-)-titanium dimethyl;
[0643] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0644] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0645] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0646] (N-(1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0647] dichloro(N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0648] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0649] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0650] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0651] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0652] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0653] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0654] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0655] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0656] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0657] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0658] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0659] dichloro(N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0660] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0661] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0662] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0663] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl; and
[0664] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene.
[0665] dichloro(N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0666] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0667] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0668] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0669] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl;
[0670] (N-(1,1-dimethylethyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene;
[0671] dichloro(N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium;
[0672] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethyl;
[0673] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0674] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0675] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (III) 2-(N,N-dimethylamino)benzyl; and
[0676] (N-(cyclohexyl)-1,1-bis(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (II) 1,4-diphenyl-1,3-butadiene.
[0677] Examples of complexes according to preferred embodiment C) correspond to the formulas:
[0678] where RFis methyl, phenyl, tolyl, or n-butylphenyl; and
[0679] R1each occurrence is trimethylsilylmethyl or two R1groups together are (dimethylsilylene)bis(methylene).
[0680] Illustrative metal complexes according to embodiment C) include (in addition to those complexes previously disclosed with respect to embodiments A) and B)):
[0681] (N-(1,1-dimethylethyl)-1,1-dimethyl-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)N-)-titanium bis(trimethylsilylmethyl);
[0682] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)N-)-titanium bis(trimethylsilylmethyl);
[0683] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0684] (N-(cyclohexyl)-1,1-dimethyl-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)N-)-titanium bis(trimethylsilylmethyl);
[0685] (N-(cyclohexyl)-1,1-diphenyl-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)N-)-titanium bis(trimethylsilylmethyl);
[0686] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0687] (N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2)-N-)-titanium bis(trimethylsilylmethyl);
[0688] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2)-N-)-titanium bis(trimethylsilylmethyl);
[0689] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0690] (N-(cyclohexyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2)-N-)-titanium bis(trimethylsilylmethyl);
[0691] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2)-N-)-titanium bis(trimethylsilylmethyl);
[0692] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2)-N-)-titanium bis(trimethylsilylmethyl);
[0693] (N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2)-N-)-titanium bis(trimethylsilylmethyl);
[0694] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2)-N-)-titanium bis(trimethylsilylmethyl);
[0695] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0696] (N-(cyclohexyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2)-N-)-titanium bis(trimethylsilylmethyl);
[0697] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2)-N-)-titanium bis(trimethylsilylmethyl);
[0698] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2)-N-)-titanium bis(trimethylsilylmethyl);
[0699] (N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2)-N-)-titanium bis(trimethylsilylmethyl);
[0700] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl-1H-inden-1-yl)silanaminato-(2)-N-)-titanium bis(trimethylsilylmethyl);
[0701] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl-1H-inden-1-yl)silanaminato-(2)-N-)-titanium bis(trimethylsilylmethyl);
[0702] (N-(cyclohexyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2)-N-)-titanium bis(trimethylsilylmethyl);
[0703] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2)-N-)-titanium bis(trimethylsilylmethyl);
[0704] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2)-N-)-titanium bis(trimethylsilylmethyl);
[0705] (N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0706] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0707] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0708] (N-(cyclohexyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0709] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0710] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0711] (N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0712] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0713] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0714] (N-(cyclohexyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0715] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0716] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0717] (N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0718] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-,n)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0719] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0720] (N-(cyclohexyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0721] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0722] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl bis(trimethylsilylmethyl;
[0723] (N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0724] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0725] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0726] (N-(cyclohexyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0727] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0728] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0729] (N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0730] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0731] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0732] (N-(cyclohexyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0733] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0734] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0735] (N-(cyclohexyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0736] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0737] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0738] (N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0739] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0740] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0741] (N-(cyclohexyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0742] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl);
[0743] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl).
[0744] (N-(1,1-dimethylethyl)-1,1-dimethyl-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0745] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0746] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0747] (N-(cyclohexyl)-1,1-dimethyl-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)titanium (dimethylsilylene)bis(methylene);
[0748] (N-(cyclohexyl)-1,1-diphenyl-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)titanium (dimethylsilylene)bis(methylene);
[0749] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-(tetramethyl-η-cyclopentadienyl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0750] (N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0751] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0752] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0753] (N-(cyclohexyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0754] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0755] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)1-1-((1,2,3,3a,7a-η)-1-methyl-4-phenyl-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0756] (N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0757] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0758] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0759] (N-(cyclohexyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0760] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0761] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0762] (N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0763] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0764] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0765] (N-(cyclohexyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0766] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1-pyridinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0767] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(2,3,4,5-tetrahydro-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0768] (N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0769] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0770] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0771] (N-(cyclohexyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0772] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0773] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0774] (N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0775] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0776] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethylsilylene)bis(methylene);
[0777] (N-(cyclohexyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0778] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0779] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,2,3,4-tetrahydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0780] (N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0781] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0782] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0783] (N-(cyclohexyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0784] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0785] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium bis(trimethylsilylmethyl bis(trimethylsilylmethyl;
[0786] (N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0787] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0788] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0789] (N-(cyclohexyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0790] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[e]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0791] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-benzo[f]isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium dimethylsilylene)bis(methylene);
[0792] (N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0793] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0794] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0795] (N-(cyclohexyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0796] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0797] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0798] (N-(cyclohexyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0799] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0800] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-[1H-benzo[de]isoquinolin-2(3H)-yl]-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0801] (N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0802] (N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0803] (N-(1,1-dimethylethyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0804] (N-(cyclohexyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene);
[0805] (N-(cyclohexyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene); and
[0806] (N-(cyclohexyl)-1,1-bis(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(N,N-dibenzylamino)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (dimethylsilylene)bis(methylene).
[0807] The complexes can be prepared by use of well known synthetic techniques. The reactions are conducted in a suitable noninterfering solvent at a temperature from −100 to 300° C., preferably from −78 to 100° C., most preferably from 0 to 50° C. Suitable reaction media for the formation of the complexes include aliphatic and aromatic hydrocarbons, ethers, and cyclic ethers, particularly branched-chain hydrocarbons such as isobutane, butane, pentane, hexane, heptane, octane, and mixtures thereof; cyclic and alicyclic hydrocarbons such as cyclohexane, cycloheptane, methylcyclohexane, methylcycloheptane, and mixtures thereof; aromatic and hydrocarbyl-substituted aromatic compounds such as benzene, toluene, and xylene, C1-4dialkyl ethers, C1-4dialkyl ether derivatives of (poly)alkylene glycols, and tetrahydrofuran. Mixtures of the foregoing are also suitable.
[0808] Optionally a reducing agent can be employed to produce the lower oxidation state complexes. By the term “reducing agent” herein is meant a metal or compound which, under reducing conditions causes the metal M, to be reduced from a higher to a lower oxidation state. Examples of suitable metal reducing agents are alkali metals, alkaline earth metals, aluminum and zinc, alloys of alkali metals or alkaline earth metals such as sodium/mercury amalgam and sodium/potassium alloy. Examples of suitable reducing agent compounds are sodium naphthalenide, potassium graphite, lithium alkyls, lithium or potassium alkadienyls; and Grignard reagents. Most preferred reducing agents are the alkali metals or alkaline earth metals, especially lithium and magnesium metal. Suitable techniques for preparing complexes of the present invention are well known to the skilled artisan and may be readily derived from techniques taught, for example, in the previously mentioned publication, WO98/06727 (U.S. Ser. No. 230,185, filed Jul. 28, 1997).
[0809] The complexes are rendered catalytically active by combination with an activating cocatalyst or use of an activating technique, such as those that are previously known in the art for use with Group 4 metal olefin polymerization complexes. Suitable activating cocatalysts for use herein include polymeric or oligomeric alumoxanes, especially methylalumoxane, triisobutyl aluminum modified methylalumoxane, or isobutylalumoxane; neutral Lewis acids, such as C1-30hydrocarbyl substituted Group 13 compounds, especially tri(hydrocarbyl)aluminum- or tri(hydrocarbyl)boron compounds and halogenated (including perhalogenated) derivatives thereof, having from 1 to 10 carbons in each hydrocarbyl or halogenated hydrocarbyl group, more especially perfluorinated tri(aryl)boron compounds, and most especially tris(pentafluorophenyl)borane; nonpolymeric, compatible, noncoordinating, ion forming compounds (including the use of such compounds under oxidizing conditions), especially the use of ammonium-, phosphonium-, oxonium-, carbonium-, silylium- or sulfonium-salts of compatible, noncoordinating anions, or ferrocenium salts of compatible, noncoordinating anions; bulk electrolysis (explained in more detail hereinafter); and combinations of the foregoing activating cocatalysts and techniques. The foregoing activating cocatalysts and activating techniques have been previously taught with respect to different metal complexes in the following references: EP-A-277,003, U.S. Pat. No. 5,153,157, U.S. Pat. No. 5,064,802, U.S. Pat. No. 5,321,106, U.S. Pat. No. 5,721,185, U.S. Pat. No. 5,350,723, U.S. Pat. No. 5,425,872, U.S. Pat. No. 5,625,087, U.S. Pat. No. 5,883,204, U.S. Pat. No. 5,919,983, U.S. Pat. No. 5,783,512, WO 99/15534, and U.S. Ser. No. 09/251,664, filed Feb. 17, 1999.
[0810] Combinations of neutral Lewis acids, especially the combination of a trialkylaluminum compound having from 1 to 4 carbons in each alkyl group and a halogenated tri(hydrocarbyl)boron compound having from 1 to 20 carbons in each hydrocarbyl group, especially tris(pentafluorophenyl)borane, further combinations of such neutral Lewis acid mixtures with a polymeric or oligomeric alumoxane, and combinations of a single neutral Lewis acid, especially tris(pentafluorophenyl)borane with a polymeric or oligomeric alumoxane are especially desirable activating cocatalysts. Preferred molar ratios of Group 4 metal complex:tris(pentafluorophenylborane:alumoxane are from 1:1:1 to 1:10:30, more preferably from 1:1:1.5 to 1:5:10.
[0811] Suitable ion forming compounds useful as cocatalysts in one embodiment of the present invention comprise a cation which is a Bronsted acid capable of donating a proton, and a compatible, noncoordinating anion, A−. As used herein, the term “noncoordinating” means an anion or substance which either does not coordinate to the Group 4 metal containing precursor complex and the catalytic derivative derived therefrom, or which is only weakly coordinated to such complexes thereby remaining sufficiently labile to be displaced by a neutral Lewis base. A noncoordinating anion specifically refers to an anion which when functioning as a charge balancing anion in a cationic metal complex does not transfer an anionic substituent or fragment thereof to said cation thereby forming neutral complexes. “Compatible anions” are anions which are not degraded to neutrality when the initially formed complex decomposes and are noninterfering with desired subsequent polymerization or other uses of the complex.
[0812] Preferred anions are those containing a single coordination complex comprising a charge-bearing metal or metalloid core which anion is capable of balancing the charge of the active catalyst species (the metal cation) which may be formed when the two components are combined. Also, said anion should be sufficiently labile to be displaced by olefinic, diolefinic and acetylenically unsaturated compounds or other neutral Lewis bases such as ethers or nitrites. Suitable metals include, but are not limited to, aluminum, gallium, niobium or tantalum. Suitable metalloids include, but are not limited to, boron, phosphorus, and silicon. Compounds containing anions which comprise coordination complexes containing a single metal or metalloid atom are, of course, well known and many, particularly such compounds containing a single boron atom in the anion portion, are available commercially.
[0813] Preferably such cocatalysts may be represented by the following general formula:
[0814] (L*—H)d+(A)d−
[0815] wherein:
[0816] L* is a neutral Lewis base;
[0817] (L*—H)+ is a conjugate Bronsted acid of L*;
[0818] Ad− is a noncoordinating, compatible anion having a charge of d−, and
[0819] d is an integer from 1 to 3.
[0820] More preferably Ad− corresponds to the formula: [M′Q4]−;
[0821] wherein:
[0822] M′ is boron or aluminum in the +3 formal oxidation state; and
[0823] Q independently each occurrence is selected from hydride, dialkylamido, halide, hydrocarbyl, hydrocarbyloxide, halo-substituted hydrocarbyl, halo-substituted hydrocarbyloxy, and halo-substituted silylhydrocarbyl radicals (including perhalogenated hydrocarbyl-perhalogenated hydrocarbyloxy- and perhalogenated silylhydrocarbyl radicals), said Q having up to 20 carbons with the proviso that in not more than one occurrence is Q halide. Examples of suitable hydrocarbyloxide Q groups are disclosed in U.S. Pat. No. 5,296,433.
[0824] In a more preferred embodiment, d is one, that is, the counter ion has a single negative charge and is A−. Activating cocatalysts comprising boron which are particularly useful in the preparation of catalysts of this invention may be represented by the following general formula:
[0825] (L*—H)+(BQ4)−;
[0826] wherein:
[0827] L* is as previously defined;
[0828] B is boron in a formal oxidation state of 3; and
[0829] Q is a hydrocarbyl-, hydrocarbyloxy-, fluorohydrocarbyl-, fluorohydrocarbyloxy-, hydroxyfluorohydrocarbyl-, dihydrocarbylaluminumoxyfluorohydrocarbyl-, or fluorinated silylhydrocarbyl-group of up to 20 nonhydrogen atoms, with the proviso that in not more than one occasion is Q hydrocarbyl. Most preferably, Q is each occurrence a fluorinated aryl group, especially, a pentafluorophenyl group.
[0830] Preferred Lewis base salts are ammonium salts, more preferably trialkylammonium salts containing one or more C12-40alkyl groups.
[0831] Illustrative, but not limiting, examples of boron compounds which may be used as an activating cocatalyst in the preparation of the improved catalysts of this invention are tri-substituted ammonium salts such as:
[0832] trimethylammonium tetrakis(pentafluorophenyl) borate,
[0833] triethylammonium tetrakis(pentafluorophenyl) borate,
[0834] tripropylammonium tetrakis(pentafluorophenyl) borate,
[0835] tri(n-butyl)ammonium tetrakis(pentafluorophenyl) borate,
[0836] tri(sec-butyl)ammonium tetrakis(pentafluorophenyl) borate,
[0837] N,N-dimethylanilinium tetrakis(pentafluorophenyl) borate,
[0838] N,N-dimethylanilinium n-butyltris(pentafluorophenyl) borate,
[0839] N,N-dimethylanilinium benzyltris(pentafluorophenyl) borate,
[0840] N,N-dimethylanilinium tetrakis(4-(t-butyldimethylsilyl)-2,3,5,6-tetrafluorophenyl) borate,
[0841] N,N-dimethylanilinium tetrakis(4-(triisopropylsilyl)-2,3,5,6-tetrafluorophenyl) borate,
[0842] N,N-dimethylanilinium pentafluorophenoxytris(pentafluorophenyl) borate,
[0843] N,N-diethylanilinium tetrakis(pentafluorophenyl) borate,
[0844] N,N-dimethyl-2,4,6-trimethylanilinium tetrakis(pentafluorophenyl) borate,
[0845] dimethyltetradecylammonium tetrakis(pentafluorophenyl) borate,
[0846] dimethylhexadecylammonium tetrakis(pentafluorophenyl) borate,
[0847] dimethyloctadecylammonium tetrakis(pentafluorophenyl) borate,
[0848] methylditetradecylammonium tetrakis(pentafluorophenyl) borate,
[0849] methylditetradecylammonium (hydroxyphenyl)tris(pentafluorophenyl) borate,
[0850] methylditetradecylammonium (diethylaluminoxyphenyl)tris(pentafluorophenyl) borate,
[0851] methyldihexadecylammonium tetrakis(pentafluorophenyl) borate,
[0852] methyldihexadecylammonium (hydroxyphenyl)tris(pentafluorophenyl) borate,
[0853] methyldihexadecylammonium (diethylaluminoxyphenyl)tris(pentafluorophenyl) borate,
[0854] methyldioctadecylammonium tetrakis(pentafluorophenyl) borate,
[0855] methyldioctadecylammonium (hydroxyphenyl)tris(pentafluorophenyl) borate,
[0856] methyldioctadecylammonium (diethylaluminoxyphenyl)tris(pentafluorophenyl) borate,
[0857] mixtures of the foregoing,
[0858] dialkyl ammonium salts such as:
[0859] di-(i-propyl)ammonium tetrakis(pentafluorophenyl) borate,
[0860] methyloctadecylammonium tetrakis(pentafluorophenyl) borate,
[0861] methyloctadodecylammonium tetrakis(pentafluorophenyl) borate, and
[0862] dioctadecylammonium tetrakis(pentafluorophenyl) borate;
[0863] tri-substituted phosphonium salts such as:
[0864] triphenylphosphonium tetrakis(pentafluorophenyl) borate,
[0865] methyldioctadecylphosphonium tetrakis(pentafluorophenyl) borate, and
[0866] tri(2,6-dimethylphenyl)phosphonium tetrakis(pentafluorophenyl) borate;
[0867] di-substituted oxonium salts such as:
[0868] diphenyloxonium tetrakis(pentafluorophenyl) borate,
[0869] di(o-tolyl)oxonium tetrakis(pentafluorophenyl) borate, and
[0870] di(octadecyl)oxonium tetrakis(pentafluorophenyl) borate;
[0871] di-substituted sulfonium salts such as:
[0872] di(o-tolyl)sulfonium tetrakis(pentafluorophenyl) borate, and
[0873] methylcotadecylsulfonium tetrakis(pentafluorophenyl) borate.
[0874] Preferred (L*—H)+ cations are methyldioctadecylammonium and dimethyloctadecylammonium. The use of the above Bronsted acid salts as activating cocatalysts for addition polymerization catalysts is known in the art, having been disclosed in U.S. Pat. Nos. 5,064,802, 5,919,983, 5,783,512 and elsewhere.
[0875] Another suitable ion forming, activating cocatalyst comprises a salt of a cationic oxidizing agent and a noncoordinating, compatible anion represented by the formula:
[0876] (Oxe+)d(Ad−)e.
[0877] wherein:
[0878] Oxe+ is a cationic oxidizing agent having a charge of e+;
[0879] e is an integer from 1 to 3; and
[0880] Ad− and d are as previously defined.
[0881] Examples of cationic oxidizing agents include: ferrocenium, hydrocarbyl-substituted ferrocenium, Ag+, or Pb+2. Preferred embodiments of Ad− are those anions previously defined with respect to the Bronsted acid containing activating cocatalysts, especially tetrakis(pentafluorophenyl)borate. The use of the above salts as activating cocatalysts for addition polymerization catalysts is known in the art, having been disclosed in U.S. Pat. No. 5,321,106.
[0882] Another suitable ion forming, activating cocatalyst comprises a compound which is a salt of a carbenium ion and a noncoordinating, compatible anion represented by the formula:
[0883] Ĉ+A−
[0884] wherein:
[0885] Ĉ+ is a C1-20carbenium ion; and
[0886] A− is as previously defined. A preferred carbenium ion is the trityl cation, that is triphenylmethylium. The use of the above carbenium salts as activating cocatalysts for addition polymerization catalysts is known in the art, having been disclosed in U.S. Pat. No. 5,350,723.
[0887] A further suitable ion forming, activating cocatalyst comprises a compound which is a salt of a silylium ion and a noncoordinating, compatible anion represented by the formula:
[0888] R3Si(X′)q+A−
[0889] wherein:
[0890] R is C1-10hydrocarbyl, and X′, q and A− are as previously defined.
[0891] Preferred silylium salt activating cocatalysts are trimethylsilylium tetrakispentafluorophenylborate, triethylsilylium tetrakispentafluorophenylborate and ether substituted adducts thereof. The use of the above silylium salts as activating cocatalysts for addition polymerization catalysts is known in the art, having been disclosed in U.S. Pat. No. 5,625,087.
[0892] Certain complexes of alcohols, mercaptans, silanols, and oximes with tris(pentafluorophenyl)borane are also effective catalyst activators and may be used according to the present invention. Such cocatalysts are disclosed in U.S. Pat. No. 5,296,433.
[0893] Another class of suitable catalyst activators are expanded anionic compounds corresponding to the formula:
[0894] (A1+a)b(Z1J1j)−c1d,
[0895] wherein:
[0896] A1is a cation of charge +a1,
[0897] Z1is an anion group of from 1 to 50, preferably 1 to 30 atoms, not counting hydrogen atoms, further containing two or more Lewis base sites;
[0898] J1independently each occurrence is a Lewis acid coordinated to at least one Lewis base site of Z1, and optionally two or more such J1groups may be joined together in a moiety having multiple Lewis acidic functionality,
[0899] J1is a number from 2 to 12 and a1, b1, c1, and d1are integers from 1 to 3, with the proviso that a1×b1is equal to c1×d1.
[0900] The foregoing cocatalysts (illustrated by those having imidazolide, substituted imidazolide, imidazolinide, substituted imidazolinide, benzimidazolide, or substituted benzimidazolide anions) may be depicted schematically as follows:
[0901] wherein:
[0902] A1+ is a monovalent cation as previously defined, and preferably is a trihydrocarbyl ammonium cation, containing one or two C10-40alkyl groups, especially the methylbis(tetradecyl)ammonium- or methylbis(octadecyl)ammonium-cation,
[0903] R8, independently each occurrence, is hydrogen or a halo, hydrocarbyl, halocarbyl, halohydrocarbyl, silyihydrocarbyl, or silyl, (including mono-, di- and tri(hydrocarbyl)silyl) group of up to 30 atoms not counting hydrogen, preferably C1-20alkyl, and
[0904] J1is tris(pentafluorophenyl)borane or tris(pentafluorophenyl)aluminane.
[0905] Examples of these catalyst activators include the trihydrocarbylammonium-, especially, methylbis(tetradecyl)ammonium- or methylbis(octadecyl)ammonium-salts of:
[0906] bis(tris(pentafluorophenyl)borane)imidazolide,
[0907] bis(tris(pentafluorophenyl)borane)-2-undecylimidazolide, bis(tris(pentafluorophenyl)borane)-2-heptadecylimidazolide, bis(tris(pentafluorophenyl)borane)-4,5-bis(undecyl)imidazolide,
[0908] bis(tris(pentafluorophenyl)borane)-4,5-bis(heptadecyl)imidazolide,
[0909] bis(tris(pentafluorophenyl)borane)imidazolinide,
[0910] bis(tris(pentafluorophenyl)borane)-2-undecylimidazolinide, bis(tris(pentafluorophenyl)borane)-2-heptadecylimidazolinide, bis(tris(pentafluorophenyl)borane)-4,5-bis(undecyl)imidazolinide,
[0911] bis(tris(pentafluorophenyl)borane)-4,5-bis(heptadecyl)imidazolinide,
[0912] bis(tris(pentafluorophenyl)borane)-5,6-dimethylbenzimidazolide,
[0913] bis(tris(pentafluorophenyl)borane)-5,6-bis(undecyl)benzimidazolide,
[0914] bis(tris(pentafluorophenyl)alumane)imidazolide,
[0915] bis(tris(pentafluorophenyl)alumane)-2-undecylimidazolide, bis(tris(pentafluorophenyl)alumane)-2-heptadecylimidazolide, bis(tris(pentafluorophenyl)alumane)-4,5-bis(undecyl)imidazolide,
[0916] bis(tris(pentafluorophenyl)alumane)-4,5-bis(heptadecyl)imidazolide,
[0917] bis(tris(pentafluorophenyl)alumane)imidazolinide,
[0918] bis(tris(pentafluorophenyl)alumane)-2-undecylimidazolinide, bis(tris(pentafluorophenyl)alumane)-2-heptadecylimidazolinide, bis(tris(pentafluorophenyl)alumane)-4,5-bis(undecyl)imidazolinide,
[0919] bis(tris(pentafluorophenyl)alumane)-4,5-bis(heptadecyl)imidazolinide,
[0920] bis(tris(pentafluorophenyl)alumane)-5,6-dimethylbenzimidazolide, and
[0921] bis(tris(pentafluorophenyl)alumane)-5,6-bis(undecyl)benzimidazolide.
[0922] A further class of suitable activating cocatalysts include cationic Group 13 salts corresponding to the formula:
[0923] [M″Q12L′1′]+(Arf3M′Q2)−
[0924] wherein:
[0925] M″ is aluminum, gallium, or indium;
[0926] M′ is boron or aluminum;
[0927] Q1is C1-20hydrocarbyl, optionally substituted with one or more groups which independently each occurrence are hydrocarbyloxy, hydrocarbylsiloxy, hydrocarbylsilylamino, di(hydrocarbylsilyl)amino, hydrocarbylamino, di(hydrocarbyl)amino, di(hydrocarbyl)phosphino, or hydrocarbylsulfido groups having from 1 to 20 atoms other than hydrogen, or, optionally, two or more Q1groups may be covalently linked with each other to form one or more fused rings or ring systems;
[0928] Q2is an alkyl group, optionally substituted with one or more cycloalkyl or aryl groups, said Q2having from 1 to 30 carbons;
[0929] L′ is a monodentate or polydentate Lewis base, preferably L′ is reversibly coordinated to the metal complex such that it may be displaced by an olefin monomer, more preferably L′ is a monodentate Lewis base;
[0930] L′ is a number greater than zero indicating the number of Lewis base moieties, L′, and
[0931] Arfindependently each occurrence is an anionic ligand group; preferably Arfis selected from the group consisting of halide, C1-20halohydrocarbyl, and Q1ligand groups, more preferably Arfis a fluorinated hydrocarbyl moiety of from 1 to 30 carbon atoms, most preferably Arfis a fluorinated aromatic hydrocarbyl moiety of from 6 to 30 carbon atoms, and most highly preferably Arfis a perfluorinated aromatic hydrocarbyl moiety of from 6 to 30 carbon atoms.
[0932] Examples of the foregoing Group 13 metal salts are alumicinium tris(fluoroaryl)borates or gallicinium tris(fluoroaryl)borates corresponding to the formula: [M″Q12L′1′]+(Arf3BQ2)−, wherein M″ is aluminum or gallium; Q2is C 1-20hydrocarbyl, preferably C1-8alkyl; Arfis perfluoroaryl, preferably pentafluorophenyl; and Q2is C1-8alkyl, preferably C1-8alkyl. More preferably, Q1and Q2are identical C1-8alkyl groups, most preferably, methyl, ethyl or octyl.
[0933] The foregoing activating cocatalysts may also be used in combination. An especially preferred combination is a mixture of a tri(hydrocarbyl)aluminum or tri(hydrocarbyl)borane compound having from 1 to 4 carbons in each hydrocarbyl group or an ammonium borate with an oligomeric or polymeric alumoxane compound.
[0934] The molar ratio of catalyst/cocatalyst employed preferably ranges from 1:10,000 to 100:1, more preferably from 1:5000 to 10:1, most preferably from 1:1000 to 1:1. Alumoxane, when used by itself as an activating cocatalyst, is employed in large quantity, generally at least 100 times the quantity of metal complex on a molar basis. Tris(pentafluorophenyl)borane, where used as an activating cocatalyst is employed in a molar ratio to the metal complex of form 0.5:1 to 10:1, more preferably from 1:1 to 6:1 most preferably from 1:1 to 5:1. The remaining activating cocatalysts are generally employed in approximately equimolar quantity with the metal complex.
[0935] The catalysts, whether or not supported in any suitable manner, may be used to polymerize ethylenically unsaturated monomers having from 2 to 100,000 carbon atoms either alone or in combination. Preferred addition polymerizable monomers for use herein include olefins, diolefins and mixtures thereof Preferred olefins are aliphatic or aromatic compounds containing vinylic unsaturation as well as cyclic compounds containing ethylenic unsaturation. Examples of the latter include cyclobutene, cyclopentene, norbornene, and norbornene derivatives that are substituted in the 5- and 6-positions with C1-20hydrocarbyl groups. Preferred diolefins are C4-40diolefin compounds, including ethylidene norbornene, 1,4-hexadiene, norbornadiene, and the like. The catalysts and processes herein are especially suited for use in preparation of ethylene/1-butene, ethylene/1-hexene, ethylene/styrene, ethylene/propylene, ethylene/1-pentene, ethylene/4-methyl-1-pentene and ethylene/1-octene copolymers as well as terpolymers of ethylene, propylene and a nonconjugated diene, such as, for example, EPDM terpolymers.
[0936] Most preferred monomers include the C2-20α-olefins, especially ethylene, propylene, isobutylene, 1-butene, 1-pentene, 1-hexene, 3-methyl-1-pentene, 4-methyl-1-pentene, 1-octene, 1-decene, long chain macromolecular α-olefins, and mixtures thereof. Other preferred monomers include styrene, C1-4alkyl substituted styrene, ethylidenenorbornene, 1,4-hexadiene, 1,7-octadiene, vinylcyclohexane, 4-vinylcyclohexene, divinylbenzene, and mixtures thereof with ethylene. Long chain macromolecular α-olefins are vinyl terminated polymeric remnants formed in situ during continuous solution polymerization reactions. Under suitable processing conditions such long chain macromolecular units are readily polymerized into the polymer product along with ethylene and other short chain olefin monomers to give small quantities of long chain branching in the resulting polymer.
[0937] Preferred monomers include a combination of ethylene and one or more comonomers selected from monovinyl aromatic monomers, 4-vinylcyclohexene, vinylcyclohexane, norbornadiene, ethylidene-norbornene, C3-10aliphatic α-olefins (especially propylene, isobutylene, 1-butene, 1-hexene, 3-methyl-1-pentene, 4-methyl-1-pentene, and 1-octene), and C4-40dienes. Most preferred monomers are mixtures of ethylene and styrene; mixtures of ethylene, propylene and styrene; mixtures of ethylene, styrene and a nonconjugated diene, especially ethylidenenorbornene or 1,4-hexadiene, and mixtures of ethylene, propylene and a nonconjugated diene, especially ethylidenenorbornene or 1,4-hexadiene.
[0938] In general, the polymerization may be accomplished at conditions well known in the prior art for Ziegler-Natta or Kaminsky-Sinn type polymerization reactions, that is, temperatures from 0-250° C., preferably 30 to 200° C. and pressures from atmospheric to 10,000 atmospheres. Suspension, solution, slurry, gas phase, solid state powder polymerization or other process condition may be employed if desired. A support, especially silica, alumina, or a polymer (especially poly(tetrafluoroethylene) or a polyolefin) may be employed, and desirably is employed when the catalysts are used in a gas phase polymerization process. The support is preferably employed in an amount to provide a weight ratio of catalyst (based on metal):support from 1:106to 1:103, more preferably from 1:106to 1:104.
[0939] In most polymerization reactions the molar ratio of catalyst:polymerizable compounds employed is from 10−12:1 to 10−1:1, more preferably from 10−9:1 to 10−5:1.
[0940] Suitable solvents use for solution polymerization are liquids that are substantially inert under process conditions encountered in their usage. Examples include straight and branched-chain hydrocarbons such as isobutane, butane, pentane, hexane, heptane, octane, and mixtures thereof; cyclic and alicyclic hydrocarbons such as cyclohexane, cycloheptane, methylcyclohexane, methylcycloheptane, and mixtures thereof; perfluorinated hydrocarbons such as perfluorinated C4-10alkanes, and alkyl-substituted aromatic compounds such as benzene, toluene, xylene, and ethylbenzene. Suitable solvents also include liquid olefins which may act as monomers or comonomers.
[0941] The catalysts may be utilized in combination with at least one additional homogeneous or heterogeneous polymerization catalyst in the same reactor or in separate reactors connected in series or in parallel to prepare polymer blends having desirable properties. An example of such a process is disclosed in WO 94/00500.
[0942] The catalysts of the present invention are particularly advantageous for the production of ethylene homopolymers and ethylene/α-olefin copolymers having high levels of long chain branching. The use of the catalysts of the present invention in continuous polymerization processes, especially continuous, solution polymerization processes, allows for elevated reactor temperatures which favor the formation of vinyl terminated polymer chains that may be incorporated into a growing polymer, thereby giving a long chain branch. The use of the present catalyst compositions advantageously allows for the economical production of ethylene/α-olefin copolymers having processability similar to high pressure, free radical produced low density polyethylene.
[0943] The present catalyst compositions may be advantageously employed to prepare olefin polymers having improved processing properties by polymerizing ethylene alone or ethylene/α-olefin mixtures with low levels of a “H” branch inducing diene, such as norbornadiene, 1,7-octadiene, or 1,9-decadiene. The unique combination of elevated reactor temperatures, high molecular weight (or low melt indices) at high reactor temperatures and high comonomer reactivity advantageously allows for the economical production of polymers having excellent physical properties and processability. Preferably such polymers comprise ethylene, a C3-20α-olefin and a “H”-branching comonomer. Preferably, such polymers are produced in a solution process, most preferably a continuous solution process.
[0944] The catalyst composition may be prepared as a homogeneous catalyst by addition of the requisite components to a solvent or diluent in which polymerization will be conducted. The catalyst composition may also be prepared and employed as a heterogeneous catalyst by adsorbing, depositing or chemically attaching the requisite components on an inorganic or organic particulated solid. Examples of such solids include, silica, silica gel, alumina, clays, expanded clays (aerogels), aluminosilicates, trialkylaluminum compounds, and organic or inorganic polymeric materials, especially polyolefins. In a preferred embodiment, a heterogeneous catalyst is prepared by reacting an inorganic compound, preferably a tri(C1-4alkyl)aluminum compound, with an activating cocatalyst, especially an ammonium salt of a hydroxyaryl(trispentafluorophenyl)borate, such as an ammonium salt of (4-hydroxy-3,5-ditertiarybutylphenyl)tris-(pentafluorophenyl)borate or (4-hydroxyphenyl)-tris(pentafluorophenyl)borate. This activating cocatalyst is deposited onto the support by coprecipitating, imbibing, spraying, or similar technique, and thereafter removing any solvent or diluent. The metal complex is added to the support, also by adsorbing, depositing or chemically attaching the same to the support, either subsequently, simultaneously or prior to addition of the activating cocatalyst.
[0945] When prepared in heterogeneous or supported form, the catalyst composition is employed in a slurry or gas phase polymerization. As a practical limitation, slurry polymerization takes place in liquid diluents in which the polymer product is substantially insoluble. Preferably, the diluent for slurry polymerization is one or more hydrocarbons with less than 5 carbon atoms. If desired, saturated hydrocarbons such as ethane, propane or butane may be used in whole or part as the diluent. Likewise, the α-olefin monomer or a mixture of different α-olefin monomers may be used in whole or part as the diluent. Most preferably, at least a major part of the diluent comprises the α-olefin monomer or monomers to be polymerized. A dispersant, particularly an elastomer, may be dissolved in the diluent utilizing techniques known in the art, if desired.
[0946] At all times, the individual ingredients as well as the recovered catalyst components must be protected from oxygen and moisture. Therefore, the catalyst components and catalysts must be prepared and recovered in an oxygen and moisture free atmosphere. Preferably, therefore, the reactions are performed in the presence of an dry, inert gas, such as, for example, nitrogen.
[0947] The polymerization may be carried out as a batchwise or a continuous polymerization process. A continuous process is preferred, in which event catalyst, ethylene, comonomer, and optionally solvent, are continuously supplied to the reaction zone, and polymer product continuously removed therefrom.
[0948] Without limiting in any way the scope of the invention, one means for carrying out such a polymerization process is as follows: In a stirred-tank reactor, the monomers to be polymerized are introduced continuously, together with solvent and an optional chain transfer agent. The reactor contains a liquid phase composed substantially of monomers, together with any solvent or additional diluent and dissolved polymer. If desired, a small amount of a “H”-branch inducing diene such as norbornadiene, 1,7-octadiene or 1,9-decadiene may also be added. Catalyst and cocatalyst are continuously introduced in the reactor liquid phase. The reactor temperature and pressure may be controlled by adjusting the solvent/monomer ratio, the catalyst addition rate, as well as by cooling or heating coils, jackets or both. The polymerization rate is controlled by the rate of catalyst addition. The ethylene content of the polymer product is determined by the ratio of ethylene to comonomer in the reactor, which is controlled by manipulating the respective feed rates of these components to the reactor. The polymer product molecular weight is controlled, optionally, by controlling other polymerization variables such as the temperature, monomer concentration, or by the previously mention chain transfer agent, such as a stream of hydrogen introduced to the reactor, as is well known in the art. The reactor effluent is contacted with a catalyst kill agent such as water. The polymer solution is optionally heated, and the polymer product is recovered by flashing off gaseous monomers as well as residual solvent or diluent at reduced pressure, and, if necessary, conducting further devolatilization in equipment such as a devolatilizing extruder. In a continuous process the mean residence time of the catalyst and polymer in the reactor generally is from about 5 minutes to 8 hours, and preferably from 10 minutes to 6 hours.
[0949] Ethylene homopolymers and ethylene/α-olefin copolymers are particularly suited for preparation according to the invention. Generally such polymers have densities from 0.85 to 0.96 g/ml. Typically the molar ratio of α-olefin comonomer to ethylene used in the polymerization may be varied in order to adjust the density of the resulting polymer. When producing materials with a density range of from 0.91 to 0.93 the comonomer to monomer ratio is less than 0.2, preferably less than 0.05, even more preferably less than 0.02, and may even be less than 0.01. In the above polymerization process hydrogen has been found to effectively control the molecular weight of the resulting polymer. Typically, the molar ratio of hydrogen to monomer is less than about 0.5, preferably less than 0.2, more preferably less than 0.05, even more preferably less than 0.02 and may even be less than 0.01.
EXAMPLES
[0950] It is understood that the present invention is operable in the absence of any component which has not been specifically disclosed. The following examples are provided in order to further illustrate the invention and are not to be construed as limiting. Unless stated to the contrary, all parts and percentages are expressed on a weight basis. The term “overnight”, if used, refers to a time of approximately 16-18 hours, “room temperature”, if used, refers to a temperature of about 20-25° C., and “mixed alkanes” refers to a mixture of hydrogenated propylene oligomers, mostly C6-C12isoalkanes, available commercially under the trademark Isopar E™ from Exxon Chemicals Inc. HRMS refers to high resolution mass spectroscopy.
[0951] All solvents were purified using the technique disclosed by Pangborn et al, Organometallics, 15, 1518-1520, (1996). All compounds, solutions, and reactions were handled under an inert atmosphere (dry box). 1H and 13C NMR shifts were referenced to internal solvent resonances and are reported relative to TMS.
[0952] X-ray analysis was performed in the following manner:
[0953] Data Collection: A single crystal of suitable dimensions was immersed in oil, Paratone N™, available from Exxon Chemicals, Inc., and mounted on a thin glass fiber. The crystal was transferred to a Bruker SMART PLATFORM diffractometer equipped with a graphite monochromatic crystal, a MoKα radiation source (λ=0.71073 Å), and a CCD (charge coupled device) area detector. The crystal was bathed in a cold nitrogen stream for the duration of data collection (−100° C.).
[0954] Program SMART (available from Bruker AXS, Inc., Madison, Wis., USA) was used for diffractometer control, frame scans, indexing, orientation matrix calculations, least squares refinement of cell parameters, crystal faces measurements and the actual data collection. Program ASTRO (available from Bruker AXS, Inc., Madison, Wis., USA) was used to set up data collection strategy.
[0955] Raw data frames were read by program SAINT (available from Bruker AXS, Inc., Madison, Wis., USA) and integrated using 3D profiling algorithms. The resulting data were reduced to produce hk1 reflections and their intensities and estimated standard deviations. The data were corrected for Lorentz and polarization effects. Sufficient reflections were collected to represent a range of 1.51 to 2.16 redundancy level with an Rsymvalue range of 2.5 percent, at the lowest 2θ shell of reflections, to 3.0 percent at the highest 2θ shell of reflections (55°). Crystal decay correction was applied and was less than 1 percent. The unit cell parameters were refined by least squares of the setting angles of the reflections.
[0956] Absorption corrections were applied by integration based on indexed measured faces. Data preparation was carried out using program XPREP (available from Bruker AXS, Inc., Madison, Wis., USA). The structure was solved by direct methods in SHELXTL5.1 (available from Bruker AXS, Inc., Madison, Wis., USA) from which the positions of all of the non-H atoms were obtained. The structure was refined, also in SHELXTL5.1, using full-matrix least-squares refinement. The non-H atoms were refined with anisotropic thermal parameters and all of the H atoms were calculated in idealized positions and refined riding on their parent atoms, or were obtained from a Difference Fourier map and refined without any constraints. A correction for secondary extinction was not applied. The final refinement was carried out using F2rather than F values. R1is calculated to provide a reference to the conventional R value but its function is not minimized. Additionally, wR2is the function that is minimized, and not R1.
[0957] The linear absorption coefficient, atomic scattering factors and anomalous-dispersion corrections were calculated from values from the International Tables for X-ray Crystallography (1974). Vol. IV, p. 55. Birmingham: Kynoch Press (Present distributor, D. Reidel, Dordrecht.).
[0958] Relevant functions:
[0959] R1=Σ(∥Fo|−|Fc∥)/Σ|Fo|
[0960] wR2=[Σ[w(Fo2−Fc2)2]/Σ[wFo22]]½
[0961] Rint.=Σ|Fo2−Fo2(mean)|2/Σ[Fo2]
[0962] S=[Σ[w(Fo2−Fc2)2]/(n−p)]½
[0963] where n is the number of reflections and p is the total number of parameters refined
[0964] w=1/[σ2(Fo2)+(0.0370*p)2+0.31*p],p=[max(Fo2,0)+2*Fc2]/3
Example 1
Preparation of Dichloro(N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)titanium
[0965]
[0966] (A) Preparation of 2,3-Dihydro-2-(1H-inden-3-yl)-1H-isoindole
[0967] 1-Indanone (10.0 g, 75.1 mmol), isoindolene (12.00 g, 100.7 mmol) and 150 mL of air free, dry toluene were loaded in a 3-necked round bottom flask equipped with a stir bar in the dry box. The stoppered flask was removed from the box, equipped with a Dean-Stark trap and refluxed under under N2. GC analysis showed major conversion complete within 7 hr (greater than 90 percent). The reaction was allowed to reflux an additional 1 h and the solvent was removed under reduced pressure (to 1 mm at 80° C.) with a short path still head. High vacuum was applied and the pot heated to 120° C. to distill off traces of amine and indanone (0.3 mm).
[0968] 1H (C6D6) δ: 7.61 (d, J=7.2 Hz, 1H), 7.32 (d, J=7.0 Hz, 1H), 6.82-7.25 (m, 6H), 5.01 (t, J=2.2 Hz, 1H), 1H), 4.59 (s, 4H), 3.14 (d, J=2.3 Hz, 2H).
[0969] 13C{1H} (C6D6) δ: 149.1, 145.9, 141.8, 138.6, 127.1, 126.8, 124.9, 124.5, 122.6, 121.1, 120.2, 100.4, 56.3, 35.8.
[0970] HRMS: Calculated. C17H15N: 233.1204, found: 233.1205.
[0971] (B) Preparation of 2,3-Dihydro-2-(1H-inden-3-yl)-1H-isoindole Lithium Salt
[0972] 2,3-Dihydro-2-(1H-inden-3-yl)-1H-isoindole (2.60 g, 1.15 mmol) was slurried in 70 mL of hexane. Toluene (70 mL) was added with stirring to form a solution. n-BuLi (2.5 M in hexane, 4.0 mL, 1.00 mmol) reagent was added over 5 minute period and stirred for 20 minutes as an olive green precipitate formed. This solid was decanted from the liquor and washed with 70 mL hexane on a frit affording the product as a free flowing olive green powder anion (1.78 g, 74 percent yield after vacuum drying). Analysis by 1H and 13C spectroscopy indicated the presence of approximately 0.33 equivalents of hexane solvate per formula weight.
[0973] 1H (THF D8) δ: 7.48 (d, J=7.2 Hz, 1H), 7.12-7.28 (m, 5H), 6.34 (m, 2H), 6.25 (d, J=3.3 Hz, 1H), 5.59 (d, J=3.4 Hz, 1H), 4.57 (s, 4H).
[0974] 13C{1H} (THF D8) δ: 142.4, 128.0, 126.8, 123.4, 122.6, 120.4, 119.7, 118.4, 113.3, 111.8, 104.4, 83.9, 60.0 (hexane at 32.5, 23.5, 14.4).
[0975] (C) [3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl]-N-(1,1-dimethylethyl)dimethyl-silanamine
[0976] 2,3-Dihydro-2-(1H-inden-3-yl)-1H-isoindole lithium salt (1.64 g, 6.86 mmol) was dissolved in 10 mL of THF and this solution was added dropwise to N-(tert-butyl)-N-(1-chloro-1,1-dimethylsilyl)amine reagent (1.47 g, 8.91 mmol, 1.3 eq) in 40 mL of THF. The reaction was allowed to stir for several hours, and THF and excess electrophile were removed under reduced pressure. The crude oil was extracted into hexane and filtered through a medium porosity frit. Solvent was removed under reduced pressure to give the desired product as an emerald green oil (2.40 g, 6.79 mmol, 96.5 percent).
[0977] 1H (C6D6) δ: 8.10 (m, 2H), 7.66 (m, 1H), 7.48 (m, 1H), 6.90-7.10 (m, 5H), 5.37 (s, 1H), 3.34 (s, 4H), 0.56 (s, 9H), −0.21 (s, 6H).
[0978] 13C{1H} (C6D6) δ: 147.9, 147.2, 140.7, 139.0, 127.1, 124.8, 124.0, 122.6, 121.0, 104.8, 56.7, 49.5, 43.8, 34.0, 0.44, −0.98; APCI/LC/MS using toluene eluent at atmospheric pressure for positive ion, m/e (percent ion) 363.1 Parent M+H+, 100 percent), 233.9 (25 percent); negative ion: 361.0, M−H+ (100 percent), 231.8 (50 percent).
[0979] (D) [3-(1,3-Dihydro-2H-isoindol-2-yl)-1H-inden-1-yl]-N-(1,1-dimethylethyl)dimethyl-silanamine, Dilithium Salt
[0980] To a 110 mL hexane solution containing 9.357 g (25.81 mmol) of [3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl]-N-(1,1-dimethylethyl)dimethyl-silanamine was added 33.9 mL of 1.6 M n-BuLi solution within 5 min. During addition of the n-BuLi, a yellow precipitate appeared. After stirring overnight, the precipitate was collected on the frit, washed with 3×25 mL of hexane and dried under reduced pressure to give 8.85 g of product as a yellow powder. Yield 91.6 percent.
[0981] (E) Preparation of Dichloro(N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)titanium
[0982] In the drybox 8.43 g (22.7 mmol) of TiCl3(THF)3was suspended in 150 mL of THF. To this solution 8.51 g (22.7 mmol) of N-(tert-butyl)-N-(1,1-dimethyl)-1-(1,3-dihydro-2H-isoindol-2-yl)-1H-indenyl)silyl)amine, dilithium salt dissolved in 100 mL of THF was added within 5 min. The solution was then stirred for 2 h. After this time 4.11 g of PbCl2(14.8 mmol) was added and the solution was stirred for 2 h. The THF was then removed under reduced pressure. Half of the remaining residue was transferred to a thimble and it was extracted with 130 mL of methylene chloride using continuous extraction outside the drybox (9 hr). The second half of the residue was extracted in substantially the same manner. Solvent was removed under reduced pressure and 80 mL of hexane was added to triturate the residue. Black-green solid was collected on the frit, washed with 2×50 mL of hexane and dried under reduced pressure to give 7.92 g of product.
[0983] Yield was 72.7 percent.
[0984] 1H (THF-d8) δ: 0.71 (s, 3H), 0.81 (s, 3H), 1.31 (s, 9H), 5.09 (d, 2H, 2JH-H=13.2 Hz), 5.48 (d, 2H, 2JH-H=13.2 Hz), 5.90 (s, 1H), 7.18-7.42 (m, 6H), 7.66 (d, 1H, 3JH-H=8.4 Hz), 8.13 (d, 1H, 3JH-H=8.7 Hz).
Example 2
Preparation of (N-(1,1-Dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)dimethyltitanium
[0985]
[0986] In the drybox 0.4 g of the dichloro(N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-1H-inden-1-yl)silanaminato-(2-)-N-)titanium (1.1 mmol) was dissolved in 35 mL of Et2O. To this solution 1.45 mL (2.32 mmol) of MeLi (1.6 M in ether) was added dropwise while stirring over a 2 minute period. After the addition of MeLi was completed, the solution was stirred for 30 minutes. Et2 O was removed under reduced pressure and the residue extracted with hexane/toluene mixture (1/1) (2×20 ml), the solution filtered, and the filtrate evaporated to dryness under reduced pressure to give 0.268 g of crystalline dark red solid. Yield was 75.5 percent. The single crystal X-ray structure (ORTEP) of the complex was obtained and is reproduced as FIG. 1 attached hereto.
[0987] 1H (C6D6) δ: 0.08 (s, 3H), 0.54 (s, 3H), 0.67 (s, 3H), 0.73 (s, 3H), 1.50 (s, 9H), 4.62 (d, 2H, 2JH-H=11.7 Hz), 5.48 (d, 2H, 2JH-H=11.7 Hz), 5.46 (s, 1H), 6.91 (t, 1H, 3JH-H=7.5 Hz), 6.98-7.13 (m, 5H), 7.52 (dd, 1H, 3JH-H=9.0 Hz, 4JH-H=1.2 Hz), 7.75 (dd, 1H, 3JH-H=8.7, Hz4JH-H=0.9 Hz). 13C{1H} (C6D6) δ: 2.37, 4.47, 34.65, 49.83, 54.54, 56.66, 58.01, 84.47, 104.34, 122.68, 124.10, 124.16, 125.11,125.48, 127.36, 128.30, 133.42, 137.80, 142.99. 13C (C6D6) δ: 49.83 (q, 1JC-H=119.0 Hz), 54.54 (q, 1JC-H=119.8 Hz).
Example 3
Preparation of Dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)titanium
[0988]
[0989] (A) Preparation of [3-(1,3-Dihydro-2H-isoindol-2-yl)-1H-inden-1-yl]-N-(1,1-dimethylethyl)diphenyl-silanamine
[0990] To a 1.73 g (5.98 mmol) of N-(tert-butyl)-N-(1-chloro-1,1-diphenyl)silylamine dissolved in 25 mL of THF was added 1.432 g (5.98 mmol) of 1-(1H-3-indenyl)-1-(2,3-dihydro-1H-isoindolinyl) lithium salt dissolved in 25 mL of THF. After the reaction mixture was stirred overnight the solvent was removed under reduced pressure. The residue was extracted with 40 mL of hexane and filtered. Solvent was removed under reduced pressure giving 3.062 of impure product as yellow-green residue.
[0991] 1H (C6D6) δ: 1.07 (s, 9H), 1.19 (s, 1H), 5.09 (d, 1H, 3JH-H=1.8 Hz), 4.36 (d, 2H, 2JH-H=11.4 Hz), 5.55 (d, 2H, 2JH-H=11.1 Hz), 5.49 (d, 1H, 3JH-H=2.4 Hz), 6.93-7.24 (m, 12H), 7.5-7.6 (m, 4H), 7.70 (m, 2H).
[0992] 13C{1H} (C6D6) δ: 33.69, 40.78, 50.03, 56.48, 103.88, 120.97, 122.50, 123.89, 124.66, 124.90, 127.00, 127.35, 127.63, 129.44, 129.48, 135.75, 135.86, 136.22, 137.00, 138.84, 141.17, 146.15, 148.54.
[0993] (B) Preparation of [3-(1,3-Dihydro-2H-isoindol-2-yl)-1H-inden-1-yl]-N-( 1,1-dimethylethyl)diphenyl-silanamine, Dilithium Salt
[0994] To a 50 mL hexane and 10 mL toluene solution containing 3.062 g (6.3 mmol) of the N-(tert-butyl)-N-(1,1-diphenyl)-1-(3-(1,3-dihydro-2H-isoindol-2-yl)-1H-indenyl)silyl)amine was added 8 mL of 1.6 M n-BuLi solution. The ligand was only partly soluble in hexane. During addition of the n-BuLi, a yellow precipitate appeared. After stirring overnight, the precipitate was collected on a frit, washed with 2×25 mL of hexane and dried under reduced pressure to give 2.50 g of product as yellow powder. Yield was 79.8 percent.
[0995] 1H (THF-d8) δ: 1.21 (s, 9H), 4.51 (4H), 6.17 (s, 1H), 6.48 (m, 2H), 7.07-7.27 (m, 10H), 7.51 (d, 1H, 3JH-H=7.8 Hz), 7.94 (m, 4H), 8.10 (d, 1H, 3JH-H=7.2 Hz).
[0996] 13C{1H} (THF-d8) δ: 38.83, 52.41, 59.78, 94.90,112.62,113.90, 116.25, 118.10, 121.69, 122.55, 124.36, 124.77, 126.02, 126.37, 126.91, 133.38, 137.22, 141.99, 151.82.
[0997] (C) Preparation of Dichloro(N-(1,1-dimethylethyl)-1,1-dipheny-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2)-N-)titanium
[0998] In the dry box 1.862 g (5.02 mmol) of TiCl3(THF)3was suspended in 20 mL of THF. To this solution 2.505 g (5.02 mmol) of [3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl]-N-(1,1-dimethylethyl)diphenyl-silanamine, dilithium salt dissolved in 30 mL of THF was added within 1 min. The solution was then stirred for 45 min. After this time 0.91 g of PbCl2(3.3 mmol) was added and the solution was stirred for 45 min. The THF was then removed under reduced pressure. The residue was first extracted with 4×30 mL of methylene chloride and filtered. Solvent was removed under reduced pressure leaving a black solid. The residue left of the frit was extracted with an additional 100 mL of methylene chloride. The solvent was removed under reduced pressure. The solids obtained from both extractions were combined and 30 mL of hexane was added. After stirring for 1 hour, the solid was collected on a frit, washed with 30 mL of hexane and dried under reduced pressure to give 1.95 g of the desired product as a deep purple solid. Yield was 64.2 percent. The single crystal X-ray structure (ORTEP) of the complex was obtained and is reproduced as FIG. 2 attached hereto.
[0999] 1H (C6D6) δ: 1.36 (s, 9H), 1.74 (m, 4H), 5.06 (d, 2H, 3JH-H=13.4 Hz), 5.47 (d, 2H, 3JH-H=12.9 Hz), 5.94 (s, 1H), 6.87 (d, 1H, 3JH-H=9.0 Hz), 7.00 (t, 1H, 3JH-H=7.7 Hz), 7.1-7.36 (m, 6H), 7.4-7.6 (m, 6H), 7.89 (m, 3H), 8.13 (d, 1H, 3JH-H=8.4 Hz).
Example 4
Preparation of (N-(1,1-Dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)dimethyltitanium
[1000] In the drybox 0.46 g of dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)titanium (0.76 mmol) was dissolved in 35 mL of diethyl ether. To this solution 1.1 mL (1.75 mmol) of MeLi (1.6 M in ether) was added dropwise while stirring over a 2 minute period. After the addition of MeLi was completed, the solution was stirred for 50 minutes. Then the ether was removed under reduced pressure and the residue extracted with a mixture of 30 mL of toluene and the solution filtered, the filtrate evaporated to dryness under reduced pressure. Hexane was added (40 mL) and the mixture was stirred for 1 hour. A red solid was collected on the frit, washed with hexane and dried under reduced pressure to give a first fraction comprising 210 mg of product. Solvent was removed from the filtrate to give 115 mg of a second fraction of the product. Total yield was 78.1 percent. The first fraction was dissolved in 3 mL of toluene followed by addition of 15 mL more toluene. The solution was filtered and put into a freezer (−27° C.) overnight. The solvent was decanted and the resulting red crystals were washed with hexane and dried under reduced pressure to give 80 mg of the desired product. The single crystal X-ray structure (ORTEP) of the complex was obtained and is reproduced as FIG. 2 attached hereto.
[1001] 1H (CD6D6) δ: 0.26 (s, 3H, H13), 0.98 (s, 3H, H12), 1.68 (s, 9H, H11), 4.52 (d, 2H, 2JH-H=11.7 Hz, H14), 4.82 (d, 2H, 2JH-H=12.0 Hz, H14), 5.65 (s, 1H, H2), 6.70 (t, 1H, 3JH-H=7.8 Hz, C6), 6.92 (dd, 2H, 3JH-H=5.4 Hz, 4JH-H=3.3 Hz, H15), 6.99 (t, 1H, 3JH-H=7.7 Hz, H5), 7.08 (dd, 2H, 3JH-H=5.5 Hz, 4JH-H=3.0 Hz, H15), 7.19 (d, 1H, 3JH-H=8.7 Hz, H7), 7.22-7.32 (m, 6H, H19, H20, H23, H24), 7.70 (d, 1H, 3JH-H=8.7 Hz, H4), 7.99 (dd, 2H, 3JH-H=8.1 Hz, 4JH-H=1.2 Hz, H18), 8.15 (m, 2H, H22).
[1002] 13C{1H} (C6D6) δ: 35.23 (C11), 51.21 (C12), 56.32 (C13), 56.61 (C14), 57.54 (C10), 83.15 (C1), 105.39 (C2), 122.69 (C15), 124.47 (quat)., 124.62 (C5), 125.18 (C6), 125.36 (C4), 127.35 (C16), 128.22, 128.35, 128.82 (C7), 130.00, 130.13, 133.49 (quat.), 136.31 (C19), 136.67 (C22), 137.45 (quat.), 137.61 (quat.), 137.95 (quat.), 143.93 (quat.). 13C (C6D6) δ: 51.21 (q, 1JC-H=118.9 Hz, C12), 56.32 (q, 1JC-H=119.9 Hz, C13).
Example 5
Preparation of Dichloro(N-(1,1-dimethylethyl)-1,1-di(p-tolyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium
[1003]
[1004] (A) Preparation of N-(tert-Butyl)-N-(1,1-p-tolyl)-1-(3-(1,3-dihydro-2H-isoindol-2-yl)-1H-indenyl)silyl)amine
[1005] To a 1.70 g (5.35 mmol) of N-(tert-butyl)-N-(1-chloro-1,1-di(3-p-tolyl)silylamine dissolved in 20 mL of THF was added 1.279 g (5.35 mmol) of 1-(1H-3-indenyl)-1-(2,3-dihydro-1H-isoindolinyl)lithium salt dissolved in 20 mL of THF. After the reaction mixture was stirred for 9 h and then solvent was removed under reduced pressure. The residue was extracted with 40 mL of hexane and filtered. Solvent was removed under reduced pressure giving 2.806 of product as a gray solid. Yield 101.9 percent.
[1006] 1H (C6D6) δ: 1.10 (s, 9H), 2.01 (s, 3H), 2.08 (s, 3H), 4.12 (d, 1H, 3JH-H=1.5 Hz), 4.39 (d, 1H, 2JH-H=11.1 Hz), 4.57 (d, 1H, 2JH-H=11.7 Hz), 5.55 (d, 1H, 3JH-H=2.1 Hz), 6.9-7.22 (m, 10H), 7.56 (d, 1H, 3JH-H=7.8 Hz), 7.62 (d, 1H, 3JH-H=6.9 Hz), 7.67 (d, 1H, 3JH-H=7.8 Hz), 7.83 (d, 1H, 3JH-H=7.8 Hz).
[1007] 13C{1H} (C6D6) δ: 21.37, 21.43, 33.78, 41.09, 50.05, 56.56, 104.28, 120.98, 122.46, 123.84, 124.71, 124.84, 126.98, 128.29, 128.52, 129.05, 132.99, 133.68, 135.08, 135.90, 136.01, 138.89, 139.05, 139.09, 141.27, 146.39, 148.48.
[1008] (B) Preparation of N-(tert-Butyl)-N-(1,1-p-tolyl)-1-(1,3-dihydro-2H-isoindol-2-yl)-1H-indenyl)silyl)amine, Dilithium Salt
[1009] To a 50 mL hexane solution containing 2.726 g (5.61 mmol) of the N-(tert-butyl)-N-(1,1-p-tolyl)-1-(3-(1,3-dihydro-2H-isoindol-2-yl)-1H-indenyl)silyl)amine was added 7.4 mL of 1.6 M n-BuLi solution. During addition of the n-BuLi, a yellow precipitate appeared. After stirring for 6 h, the yellow precipitate was collected on a frit, washed with 2×25 mL of hexane, and dried under reduced pressure to give 2.262 g of the product as a yellow powder. Yield was 76.6 percent.
[1010] 1H (C6D6) δ: 1.17 (s, 9H), 2.30 (s, 6H), 4.51 (s, 4H), 6.21 (s, 1H), 6.47 (m, 2H), 6.97 (d, 4H, 3JH-H=8.1 Hz), 7.15 (m, 2H), 7.23 (m, 2H), 7.50 (m, 1H), 7.81 (d, 4H, 3JH-H=7.8 Hz), 8.07 (d, 1H, 3JH-H=7.2 Hz). 13C{1H} (C6D6) δ: 21.65, 38.83, 52.46, 59.82, 95.33, 112.93, 114.15, 115.78, 118.29, 122.05, 122.60, 124.16, 124.78, 126.94, 127.30, 133.06, 134.75, 137.30, 141.98, 148.17.
[1011] (C) Preparation of Dichloro(N-(1,1-dimethylethyl)-1,1-di-p-tolyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)titanium
[1012] In the drybox 1.552 g (4.19 mmol) of TiCl3(THF)3was suspended in 20 mL of THF. To this solution, 2.206 g (4.19 mmol) of N-(tert-butyl)-N-(1,1-p-tolyl)-1-(1,3-dihydro-2H-isoindol-2-yl)-1H-indenyl)silyl)amine, dilithium salt dissolved in 30 mL of THF was added within 1 min. The solution was then stirred for 60 min. After this time, 0.76 g of PbCl2(2.75 mmol) was added and the solution was stirred for 60 min. The THF was then removed under reduced pressure. The residue was first extracted with 60 mL of methylene chloride and filtered. Solvent was removed under reduced pressure leaving a black crystalline solid. Hexane was added (30 mL) and the black suspension was stirred for 10 hour. The solids were collected on a frit, washed with 30 mL of hexane and dried under reduced pressure to give 2.23 g of the desired product as a deep purple solid. Yield was 88.2 percent.
[1013] 1H (THF-d8) δ: 1.40 (s, 9H), 2.46 (s, 3H), 2.48 (s, 3H), 5.07 (d, 2H, 2JH-H=12.3 Hz), 5.45 (d, 2H, 2JH-H=12.6 Hz), 5.93 (s, 1H), 6.95 (d, 1H, 3JH-H=9.0 Hz), 7.08 (d, 1H, 3JH-H=7.8 Hz), 7.15-7.4 (m, 9H), 7.76 (d, 1H, 3JH-H=7.8 Hz), 7.82 (d, 1H, 3JH-H=7.5 Hz), 8.05 (d, 1H, 3JH-H=8.7 Hz). 13C{1H} (TBF-d8) δ: 21.71, 21.76, 33.38, 56.87, 61.41, 94.5, 107.95, 122.86, 125.77, 126.68, 127.84, 127.92, 128.40, 128.49, 129.36, 129.79, 131.23, 131.29, 135.79, 136.43, 136.73, 141.02, 141.22, 150.14.
Example 6
Preparation of (N-(1,1-Dimethylethyl)-1,1-di-p-tolyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)dimethyltitanium
[1014]
[1015] In the drybox 0.50 g of dichloro(N-(1,1-dimethylethyl)-1,1-di-p-tolyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)titanium complex (0.79 mmol) was dissolved in 30 mL of diethyl ether. To this solution, 1.14 mL (1.6 mmol) of MeLi (1.6 M in ether) was added dropwise while stirring over a 1 minute period. After the addition of MeLi was completed, the solution was stirred for 1.5 hour. Diethyl ether was removed under reduced pressure and the residue extracted with 45 mL of hexane. Hexane was removed under reduced pressure giving a red crystalline material. This solid was dissolved in about 7 mL of toluene and 25 mL of hexane, filtered, and the solution was put into the freezer (−27° C.) for 2 days. The solvent was then decanted and the resulting crystals were washed with cold hexane and dried under reduced pressure to give 156 mg of product. Yield was 33.3 percent
[1016] 1H (C6D6) δ: 0.25 (s, 3H), 0.99 (3H), 1.72 (s, 9H), 2.12 (s, 3H), 2.15 (s, 3H), 4.53 (d, 2H, 2JH-H=11.7 Hz), 4.83 (d, 2H, 2JH-H=11.7 Hz), 5.68 (s, 1H), 6.72 (dd, 1H, 3JH-H=8.6 Hz, 3JH-H=6.6 Hz), 6.9-7.2 (m, 11H), 7.30 (d, 1H, 3JH-H=8.6 Hz), 7.71 (d, 1H, 3JH-H=8.5 Hz), 7.93 (d, 1H, 3JH-H=7.8 Hz), 8.11 (d, 1H, 3JH-H=7.8 Hz). 13C{1H} (C6D6) δ: 21.45, 21.52, 35.30, 50.83, 56.03, 56.66, 57.65, 83.80, 105.64, 122.69, 124.51, 124.56, 125.06, 125.35, 127.33, 128.98, 129.06, 129.22, 133.51, 134.02, 134.62, 136.49, 136.84, 137.69, 139.72, 139.87, 143.84.
Example 7
Dichloro(N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(3,4-dihydro-2(1H-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium
[1017]
[1018] (A) Preparation of 1,2,3,4-Tetrahydro-2-(1H-inden-3-yl)-isoquinoline
[1019] Tetrahydroisoquinoline (Aldrich Chemical, 18.0 g, 135.1 mmol), 1-indanone (10.0 g, 75.1 mmol) and P2O5(2.30 g, 16.1 mmol) in 150 mL of toluene were stirred under nitrogen and refluxed for 10 h with water removal via a Dean Stark apparatus. Upon cooling a large amount of fine white powder precipitated (as amine phosphate salts). The dark green solution was filtered under N2through a medium porosity frit and assayed by NMR after tolune removal (about 85:15 mole ratio of product to ketone). Solvent was evaporated and indanone/amine (about 3.0 g) was removed in vacuo (90-160° C. at 0.5 mm Hg, 76 Pa). The process was stopped and the crude enamine residue recovered under inert atmosphere, giving 18.0 g of dark red-green oil, 95 percent yield. The crude product was analyzed by 1H and 13C NMR and showed less than 2 percent mole ketone.
[1020] 1H (C6D6) δ: 7.50 (d, J=7.2 Hz, 1H), 7.29 (d, J=7.0 Hz, 1H), 6.85-7.20 (m, 6H), 5.36 (t, J=2.3 Hz), 1H), 4.11 (s, 2H), 3.20 (t, J=5.9 Hz, 2H), 3.14 (d, J=2.3 Hz, 2H) 2.74 (t, J=5.9 Hz, 2H).
[1021] 13C{1H} (C6D6) δ: 153.2 (q), 144.8(q), 142.1(q), 135.1(q), 134.8(q), 129.1, 126.8, 126.4, 126.2, 126.1, 125.2, 124.4, 120.2, 109.1, 53.5, 48.7, 35.9, 29.5.
[1022] HRMS: Calculated C18H17N: 247.1361, found: 247.1334.
[1023] (B) Preparation of 1,2,3,4-Tetrahydro-2-(1H-inden-3-yl)-isoquinoline Lithium Salt
[1024] Crude 1,2,3,4-tetrahydro-2-(1H-inden-3-yl)-isoquinoline (15.0 g, 60.6 mmol) was dissolved in 80 mL toluene and 150 mL hexane was added with stirring (emerald green solution). 38 mL of 1.6 M n-BuLi was added dropwise over 15 min and the solution became dark red. Within 10 min a brick red precipitation formed and the stir bar stopped within 15 min as the flocculent solid went to gum. After standing for 1 hr, the orange solvent was decanted and the gum was triturated with 100 mL of hexane to a fine tan powder which was easily filtered and washed with hexane (60 ml) to give 12.5 g of vacuum dried material. A second crop of orange powder was obtained from the liquid, washed with 20 mL of hexane, and combined with the first crop to give a total of 13.65 g lithium salt after vacuum drying (89 percent yield). The estimated purity of starting enamine was about 90 percent.
[1025] 1H (THF D8) δ: 7.34 (m, 1H), 7.22 (m, 1H), 6.99-7.14 (m, 4H), 6.34-6.44 (m, 3H), 5.585 (d, J=3.4 Hz, 1H), 4.16 (s, 2H), 3.29 (t, J=5.8 Hz, 2H), 3.01(t, J=5.8 Hz, 2H).
[1026] 13C{1H APT} (THF D8) δ: 138.5 (q), 136.1(q), 129.3, 127.7(q), 126.9, 126.0, 125.8, 125.4(q), 119.6, 117.3, 113.7, 112.2, 105.8, 84.0, 57.9 (CH2), 53.7(CH2), 31.5 (CH2).
[1027] (C) Preparation of N-(tert-Butyl)-N-(1,1-dimethyl-1-(3-(3,4-dihydro-2(1H)-isoquinolinyl)-1H-indenyl)silyl)amine
[1028] A solution of 1,2,3,4-tetrahydro-2-(1H-inden-3-yl)-isoquinoline lithium salt (4.0 g, 15.8 mmol) in 80 mL of THF was added within 10 min. to a 60 mL THF solution N-(tert-butyl)-N-(1-chloro-1,1-dimethylsilyl)amine (2.6 g, 15.8 mmol). After the addition was complete the reaction mixture was stirred overnight. The solvent was then removed under reduced pressure. The residue was extracted with hexane and the solution filtered. The solvent was then removed under reduced pressure leaving 5.85 g of product. Yield was 99 percent.
[1029] 1H (CDCl3) δ −0.5 (s, 3H), 0.0 (s, 3H), 1.2 (s, 9H), 3.05 (m, 2H), 3.4 (m, 2H), 3.4 (m, 1H, benzylic), 4.25(m, 2H), 5.8 (s, 1H), 7.2 (m, 6H), 7.5 (m, 2H).
[1030] 13C{1H} (CDCl3) δ: −1.1, −0.1, 29.2, 33.9, 44.0,49.3, 49.5, 53.7, 113.1, 119.4, 123.5, 123.8, 124.2, 125.7, 126.1, 126.5, 128.9, 134.4, 134.8, 140.4, 145.8, 150.6.
[1031] (D) Preparation of N-(tert-Butyl)-N-(1,1-dimethyl-1-(3-(2-(3,4-dihydro-2(1H)-isoquinolinyl)-1H-indenyl)silyl)amine, Dilithium Salt.
[1032] In the drybox 5.85 g (15.5 mmol) of N-(tert-butyl)-N-(1,1-dimethyl-1-(3-(2-(3,4-dihydro-2(1H)-isoquinolinyl)-1H-indenyl)silyl)amine was combined with 150 mL of hexane. To this solution 19.5 mL (31.2 mmol) of n-BuLi (1.6 M) was added dropwise in about 10 minutes. Upon complete addition of the n-BuLi the solution was stirred overnight. The resulting precipitate was collected via filtration, washed with 50 mL hexane and dried under reduced pressure to give 5.1 g of an off-orange powder. Yield was 85 percent.
[1033] (E) Preparation of Dichloro(N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium
[1034] N-(tert-butyl)-N-(1,1-dimethyl-1-(3-(3,4-dihydro-2(1H)-isoquinolinyl)-1H-indenyl)silyl)amine, dilithium salt (10.0 g, 25.74 mmol) was dissolved in 120 mL of THF. This solution was added to a TiCl3(TBF)3(9.54 g, 25.74 mmol) suspension in 200 mL of THF. After 1 h, PbCl2(4.65 g, 16.7 mmol) was added as a solid. The reaction mixture was then stirred an additional hour. The solvent was removed under reduced pressure. The residue was extracted with 100 mL of toluene, 150 mL of hexane were added and finally the mixture was filtered. The residue was washed with 3×60 mL of a toluene-hexane=⅓ mixture. The residue was dried in vacuo to give 5.0 g of fine black powder. The mother liquors from the filtration were placed in the freezer and a second crop of 3.75 g was collected. Yield was 71 percent.
[1035] 1H (C6D6) δ: 0.5 (s, 3H), 0.6 (s, 3H), 1.4 (s, 9H), 2.6 (m, 2H), [3.6 (m, 1H), 3.8 (m, 1H)], [4.2 (d, 1H), 4.9 (d, 1H)], 6.0 (s, 1H), 6.7 (d, 1H), 6,9 (d, 1H), 7.0 (m, 4H), 7.6 (dd, 2H).
[1036] 13C{1H} (C6D6) δ: 1.2, 3.8, 29.6, 32.7, 48.7, 51.8, 61.4, 92.7, 110.8, 125.4, 126.3, 126.7, 126.8, 128.5, 129.3, 133.7, 135.0, 135.4, 150.3.
Example 8
Preparation of (N-(1,1-Dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-dimethyl Titanium
[1037]
[1038] Dichloro(N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(2-(1,2,3,4-tetrahydro-isoquinoline))-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (10.6 g, 21.5 mmol) were dissolved in 500 mL of ether. Then 28.2 mL (45.1 mmol) of MeLi (1.6 M, ether) were added in a period of five minutes. The temperature of the mixture increased from 25° C. to 28° C. and the mixture changed from deep purple to deep brownish-red, and was stirred for one hour. The volatiles were then removed in vacuo and the residue was extracted with hexane (3×100 mL) and filtered through a diatomaceous earth bed. The filtrate was dried under reduced pressure, re-dissolved in 250 mL of hexane and filtered, leaving 1 g of dark residue. The solution was allowed to stand overnight in the freezer. Crystals were formed and the solution was decanted, the crystals were washed with cold hexane to give a mass of orange red crystals (4.9 g). A second crop of 0.95 g of good quality material was also obtained. Yield was 4.9 g+0.95 g=5.85 g (60 percent).
[1039] 1H (C6D6) δ 0.0 (s, 3H), 0.5 (s, 3H), 0.7 (s, 3H), 0.9 (s, 3H), 1.5 (s, 9H), 2.6 (m, 1H), 2.8 (m, 1H), 3.4 (m, 1H), 3.6 (m, 1H), 4.4 (dd AB, 2H), 5.9 (s, 1H), 6.8 (m, 1H), 6.9 (m, 1H), 7.1 (m, 1H), 7.5 (d, 1H), 7.7 (d, 1H). 13C{1H} (C6D6) δ: 2.1, 4.5, 29.9, 34.5, 49.0, 51.7, 53.0, 55.1, 58.2, 84.9, 108.8, 124.6, 124.8, 125.2, 126.0, 126.2, 126.6, 126.7, 129.0, 133.2, 134.5, 134.9, 144.9.
Example 9
Preparation of Dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium
[1040]
[1041] (A) Preparation of N-(tert-Butyl)-N-(1,1-diphenyl-1-(3-(3,4-dihydro-2(1H)-isoquinolinyl)-1H-indenyl)silyl)amine
[1042] A solution of 1-(1H-3-indenyl)-3-(3,4-dihydro-2(1H)-isoquinolinyl) lithium salt (1.0 g, 3.95 mmol) in 20 mL of THF was added within 10 min. to a 20 mL THF solution N-(tert-butyl)-N-(1-chloro-1,1-diphenylsilyl)amine (1.14 g, 3.95 mmol). After the addition was complete the reaction mixture was stirred overnight. The solvent was then removed under reduced pressure. The residue was extracted with hexane and the solution filtered through diatomaceous earth. The solvent was then removed under reduced pressure leaving 1.75 g of product. Yield was 86 percent.
[1043] (B) Preparation of N-(tert-Butyl)-N-(1,1-diphenyl-1-(3-(3,4-dihydro-2(1H)-isoquinolinyl)-1H-indenyl)silyl)amine Diflthium Salt
[1044] In the drybox 1.7 g (3.4 mmol) of N-(tert-butyl)-N-(1,1-diphenyl-1-(3-(3,4-dihydro-2(1H)-isoquinolinyl)-1H-indenyl)silyl)amine were dissolved in 60 mL of hexane. To this solution, 4.35 mL (7 mmol) of n-BuLi (1.6 M) was added dropwise in about 5 minutes. Upon complete addition of the n-BuLi, the solution was stirred overnight. The resulting precipitate was collected via filtration, washed with 40 mL hexane and dried under reduced pressure to give 1.5 g of product.
[1045] Yield was 86 percent.
[1046] (C) Preparation of Dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium
[1047] N-(tert-butyl)-N-(1,1-diphenyl-1-(3-(3,4-dihydro-2(1H)-isoquinolinyl)-1H-indenyl)silyl)amine, dilithium salt (1.5 g, 2.9 mmol) was dissolved in 40 mL of THF. This solution was added to a TiCl3(THF)3(1.08 g, 2.9 mmol) suspension in 40 mL of THF. After 1 h, PbCl2(0.53 g, 1.9 mmol) was added as a solid. The reaction mixture was then stirred an additional hour. The solvent was removed under reduced pressure. The residue was extracted with 60 mL of toluene and the mixture was filtered through diatomaceous earth. The filtrate was dried in vacuum and the residue was triturated with hexane. The residue was then filtered, washed with hexane and dried in vacuum to give 1.4 g of deep black-purple product. Yield was 77 percent.
[1048] 1H (C6D6) δ: 1.6 (s, 3H), 2.6 (m, 2H), [3.5 (m, 1H), 3.8 (m, 1H)], [4.1 (d, 1H), 4.9 (d, 1H)], 6.2 (s, 1H), 6.6 (d, 1H), 6.8 (m, 3H), 7.0 (m, 4H), 7.3 (m, 6H), 7.4 (d, 1H), 7.6 (d, 1H), 8.0 (d, 2H), 8.1 (d, 2H). 13C{1H} (C6D6) δ: 29.5, 33.5, 48.8, 51.8, 61.1, 112.2, 125.3, 126.3, 126.8, 128.1, 128.6, 128.7, 129.6, 130.78, 130.84, 133.5, 134.9, 136.5, 151.1.
Example 10
Preparation of (N-(1,1-Dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-) dimethyl Titanium
[1049]
[1050] Dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (0.25 g, 0.4 mmoles) was dissolved in 30 mL of ether. Then 0.5 mL (0.8 mmoles) of MeLi (1.6 M, ether) was added. The mixture was then stirred for one hour. The volatiles were removed under reduced pressure and the residue was re-dissolved in 10 mL of toluene and filtered. The filtrate was dried in vacuum and the resulting residue was re-dissolved in hexane and filtered. The filtrate was concentrated to the point were a bright orange solid started to precipitate. The solid was collected by filtration and dried to give 0.11 g of product. Yield was 47 percent.
[1051] 1H (C6D6) δ 0.2 (s, 3H), 1.2 (s, 3H), 1.7 (s, 9H), 2.6 (m, 1H), 2.8 (m, 1H), 3.25 (m, 1H), 3.6 (m, 1H), 4.2 (d, 1H), 4.5 (d, 2H), 5.9 (s, 1H), 6.6 (m, 2H), 7.0 (m, 4H), 7.25 (m, 6H), 7.6 (d, 1H), 7.8 (d, 2H), 8.2 (m, 2H).
[1052] 13C{1H} (C6D6) δ 29.9, 35.2, 49.0, 52.7, 57.7, 109.8, 124.4, 125.16, 125.24, 126.11, 126.28, 126.53, 126.79, 128.2, 128.4, 128.88, 128.91, 130.04, 130.14, 134.35, 134.8, 136.26, 136.6, 137.1, 137.8, 145.9.
Example 11
Preparation of (N-(1,1-Dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H)-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)bis(trimethylsilylmethyl) Titanium
[1053]
[1054] In the drybox, dichloro(N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)titanium complex (1.0 g, 2.1 mmol, Example 1) was partly dissolved in 40 mL of toluene. To this solution, 4.38 mL (4.38 mmol) of magnesiumchloridetrimethylsilylmethyl (MgClCH2TMS) (1 M in ether) was added dropwise while stirring over a 2 minute period. After the addition of Grignard reagent was completed, the solution was stirred for 4 h. A proton NMR spectrum of the solution showed the conversion to the dialkyl complex was incomplete. An additional quantity of MgClCH2TMS solution (2.0 mL) were added to the reaction mixture and the reaction mixture was stirred overnight. Analysis by 1H NMR showed substantially complete conversion to the dialkyl complex and residual quantities of Grignard reagent in the reaction mixture. Toluene was removed under reduced pressure and the residue was dissolved in 20 mL of hexane and filtered. The mixture volume was reduced to 14 mL and the vessel was put into a freezer for 48 hr at −27° C. The solvent was decanted and the dark red crystalline material remaining was washed with 3 mL of cold hexane. Drying under reduced pressure gave 0.32 g of pure complex.
[1055] 1H (C6D6) δ: −0.89 (d, 1H, 2JH-H=12.0 Hz), 0.09 (s, 9H), 0.18 (s, 9H), 0.59 (s, 3H), 0.69 (s, 3H), 0.87 (d, 1H, 2JH-H=11.7 Hz), 0.95 (d, 1H, 2JH-H=10.5 Hz), 1.35 (d, 1H, 2JH-H=10.8 Hz), 1.50 (s, 9H), 4.85 (s, 4H), 5.49 (s, 1H), 6.85 (ddd, 1H, 3JH-H=8.6 Hz, 3JH-H=6.6 Hz, 4JH-H=0.9 Hz), 7.0-7.1 (m, 5H), 7.56 (d, 1H, 3JH-H=8.7 Hz), 7.79 (d, 1H, 3JH-H=8.7 Hz).
[1056] 13C{1H} (C6D6) δ: 2.63, 3.14, 3.72, 4.71, 34.18, 57.00, 58.91, 69.59, 77.12, 85.60, 100.79, 122.61, 123.90, 124.24, 125.04, 125.20, 127.55, 128.45, 133.80, 137.52, 144.66.
Example 12
Preparation of (N-(1,1-Dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H)-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)bis(trimethylsilylmethyl) Titanium
[1057]
[1058] In the drybox 0.466 g of dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)titanium complex (0.77 mmol, Example 4) was partly dissolved in 25 mL of diethylether. To this solution, 1.62 mL (1.62 mmol) of MgCICH2TMS (1 M in ether) was added dropwise while stirring over a 2 minute period. After the addition of Grignard reagent was completed, the solution was stirred for 2 h. After that time, 20 mL of toluene was added with stirring continued for another 2 h. The solvent mixture was removed under reduced pressure and the residue extracted with 40 mL of hexane. The solution was filtered ad the filtrate was evaporated to dryness under reduced pressure. Extraction with hexane was repeated one more time. The solvent was removed giving 0.334 g of red solid. One half of this material was dissolved in about 4 mL of hexane and the vial was put into a freezer at −27° C. overnight. After cooling, the solution was decanted and the resulting crystalline red solid was washed with cold hexane and the dried under reduced pressure.
[1059] 1H (C6D6) δ: 0.67 (d, 1H, 2JH-H=11.7 Hz), 0.14 (s, 9H), 0.19 (s, 9H), 1.10 (d, 1H, 2JH-H=11.7 Hz), 1.32 (s, 2H), 1.68 (s, 9H), 4.75 (d, 1H, 2JH-H=12 Hz), 4.89 (d, 1H, 2JH-H=12 Hz), 5.74 (s, 1H), 6.71 (dd, 1H, 3JH-H=8.3 Hz, 3JH-H=6.9 Hz), 6.94-7.10 (m, 5H), 7.22-7.36 (m, 7H), 7.77 (d, 1H, 3JH-H=8.7 Hz), 8.02 (m, 2H), 8.12 (m, 2H).
[1060] 13C{1H} (C6D6) δ: 2.51, 3.29, 35.10, 56.81, 58.40, 69.31, 80.94, 84.08, 101.82, 122.39, 124.30, 124.65, 124.70, 125.06, 127.49, 127.90, 128.05, 129.15, 129.83, 129.90, 133.87, 136.29, 136.72, 137.19, 137.55, 137.77, 145.99.
Example 13
Preparation of (N-(1,1-Dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)bis(trimethylsilylmethyl) Titanium
[1061]
[1062] Dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)titanium (0.25 g, 0.4 mmol, Example 9) was dissolved in 30 mL of toluene. Then 0.8 mL (0.8 mmol) of MgClCH2TMS (1.0 M, diethylether) were added. The mixture was stirred for 48 hours. The solvent was removed under reduced pressure and the residue was re-dissolved in hexane and filtered. The filtrate was dried under vacuum to afford 0.2 g of a dark-red oily material. Yield was 69 percent.
[1063] 1H (C6D6) δ: −0.9 (d), 0.12 (s, 9H), 0.25 (s, 9H), 0.88 (m), 1.2 (m), 1.6 (m), 1.6 (s, 9H), 2.7 (m), 2.8 (m), 3.5 (m), 3.6 (m), 4.4 (d), 4.6 (d), 6.0 (s, 1H), 6.6 (m), 6.9 (m), 7.0 (m), 7.2 (m), 7.3 (d), 7.7 (d), 7.9 (d), 8.2 (d).
[1064] 13C{1H} (C6D6) δ: 2.3, 2.5 [Si(CH3)3], 3.1, 3.4 [Si(CH3)3], 29.6 35.0, 49.5, 53.4, 58.4, 70.0, 87.0, 107.8, 124.4, 124.9, 125.3, 126.4, 126.5, 126.7, 129.0, 129.5, 130.1, 133.4, 134.3, 134.7, 136.4, 136.6, 137.2, 137.7, 147.4.
[1065] Ethylene/1-Octene Polymerization Conditions
[1066] All liquid and gas feeds were passed through columns of alumina and a decontaminant (Q5™ catalyst available from Englehardt Chemicals Inc.) prior to introduction into the reactor. Catalyst components are handled in a glovebox containing an atmosphere of argon or nitrogen. A stirred 2.0 liter reactor is charged with about 740 g of mixed alkanes solvent and 118 g of 1-octene commoner. Hydrogen is added as a molecular weight control agent by differential pressure expansion from a 75 mL addition tank at 25 psi (0.2 MPa). The reactor is heated to the desired polymerization temperature and saturated with ethylene at 500 psig (3.4 MPa). Metal complex as a dilute toluene solution and cocatalyst as dilute solutions in toluene or methylcyclohexane, were mixed in a 1:1 molar ratio and transferred to a catalyst addition tank and injected into the reactor. The cocatalyst for all runs except 9-11 was methyldi(octadecyl)ammonium tetrakis(pentafluorophenyl)borate. (The ammonium cation of which is derived from a mixture of amines available commercially as methyl bis(tallow)amine). The cocatalyst for runs 9-11 was tris(pentafluorophenyl-borane). The polymerization conditions were maintained for 15 minutes with ethylene added on demand. The resulting solution was removed from the reactor, quenched with isopropyl alcohol, and stabilized by addition of a toluene solution containing about 67 mg/100 g polymer of a hindered phenol antioxidant (Irganox™ 1010 from Ciba Geigy Corporation) and about 133 mg/100 g polymer of a phosphorus stabilizer (Irgafos 168 from Ciba Geigy Corporation).
[1067] Between polymerization runs, a wash cycle was conducted in which 850 g of mixed alkanes was added to the reactor and the reactor was heated to 150° C. The reactor was then emptied of the heated solvent immediately before beginning a new polymerization run.
[1068] Polymers were recovered by drying in a vacuum oven set at 140° C. for about 20 hours. Density values are derived by determining the polymer's mass when in air and when immersed in methylethyl ketone. Micro melt index values (MMI) are obtained using a Custom Scientific Instrument Inc. Model CS-127 MF-015 apparatus at 190° C., and are unit less values calculated as follows: MMI=1/(0.00343 t−0.00251), where t=time in seconds as measured by the instrument. Results are contained in Table 1.
| TABLE 1 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Catalyst | Temp. | Yield | Density | Mw | ||||
| Run | (μmol) | (° C.) | (g) | Eff | (g/ml) | (×10 | Mw/Mn | MMI |
Example 14
Preparation of Dichloro(N-1,1-dimethylethyl)-1,1-(4-butyl-phenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)titanium
[1069]
[1070] A) Tetramethylsilane[MgCl]2(THF)6
[1071] To 40 mL diethyl ether solution of 2.5 g, 15.9 mmol of Me2Si(CH2Cl)2was added 0.851 g, 35.0 mmol of Mg turnings. After stirring overnight, a large amount of white solid was visible. Solvent was removed under reduced pressure and replaced with 40 mL of tetrahydrofuran (THF). Upon addition of THF, all of the white solid dissolved. After stirring an additional 24 h., about 20 mL of hexane was added and the solution was filtered. The filtrate was put into a freezer (−27° C.) overnight. Solvent was decanted and large colorless crystals were washed with cold hexane (2×20 mL). The solid was then dried under reduced pressure to give 2.753 g of product as the THF hexaadduct. Yield was 27.1 percent
[1072] 1H NMR (THF-d8): δ1.81 (s, 4H), −0.21 (s, 6H), 1.77 (m, 28H, THF), 3.66 (m, 28H, THF).
[1073] 13C{1H} NMR (TJF-d8): δ −2.50, 9.14, 26.37 (THF), 68.46 (THF).
[1074] B) Dichloro(N-(1,1-dimethylethyl)-1,1-di(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)titanium
[1075] i) Preparation of (Bu-Ph)2SiCl2.
[1076] To a three-necked 250 mL round-bottom flask under a nitrogen atmosphere equipped with a reflux condenser and a 250 mL dropping funnel 4.87 g of Mg turnings (0.200 moles) were introduced. 1-bromo-4-butyl benzene (42.6 g, 0.200 moles) and 80 mL of THF were then added to the dropping funnel. At this time 10 mL of the bromobenzene/THF solution was added to the Mg turnings with a small amount of ethyl bromide. The solution was then stirred until initiation occurred. The rest of the bromo benzene/THF solution was then added dropwise to allow refluxing to occur. After addition of the bromo benzene/THF solution, the mixture was heated at reflux until the magnesium was consumed.
[1077] The resulting Grignard solution was then transferred to a 250 mL dropping funnel which was attached to a three-necked 250 mL round-bottom flask under a nitrogen atmosphere equipped with a reflux condenser. To the round bottomed flask, 100 mL of heptane was introduced followed by SiCl4(15.3 g, 0.090 moles). To this solution, the Grignard solution was added dropwise. After addition was complete the resulting mixture was refluxed for 2 h and then allowed to cool to room temperature. Under an inert atmosphere the solution was filtered. The remaining salts were further washed with heptane (3×40 mL), filtered and combined with the original heptane solution.
[1078] The heptane was then removed via distillation at atmospheric pressure. The resulting viscous oil was then vacuum distilled with collection of the product at 1 mm Hg, (133 Pa) at 210° C. giving 19.3 g (58 percent) of the desired product.
[1079] ii) Preparation of bis(4-n-Butylphenyl)(t-butylamido)chlorosilane
[1080] Dichloro-di(4-n-butylphenyl)silane (4.572 g, 12.51 mmol) was dissolved in 45 mL of methylene chloride. To this solution was added 1.83 g, 25.03 mmol of t-BuNH2. After stirring overnight, the solvent was removed under reduced pressure. The residue was extracted with 45 mL of hexane and filtered. Solvent was removed under reduced pressure leaving 4.852 g of the desired product.
[1081] iii) Preparation of (4-n-Bu-Ph)2Si(3-isoindolino-indenyl)(NH-t-Bu)
[1082] To a 4.612 g (11.47 mmol) of (4-n-Bu-Ph)2Si(Cl)(NH-t-Bu) dissolved in 20 mL of THF was added 2.744 g (8.37 mmol) of lithium 1-isoindolino-indenide dissolved in 30 mL of THF. After the reaction mixture was stirred overnight solvent was removed under reduced pressure. The residue was extracted with 50 mL of hexane and filtered. Solvent removal gave 6.870 g of product as a very viscous red-brown oil. Yield was 91.0 percent.
[1083] iv) Preparation of Dilithium Salt of (4-n-Bu-Ph)2Si(3-isoindolino4 ndenyl)(NH-t-Bu)
[1084] To a 50 mL of hexane solution containing 6.186 g (10.33 mmol) of (4-n-Bu-Ph)2Si(3-isoindolino-indenyl)(NH-t-Bu) was added 13.5 mL of 1.6 M n-BuLi solution. A few minutes after n-BuLi addition, a yellow precipitate appeared. After stirring overnight, the yellow precipitate was collected on the frit, washed with 4×20 mL of hexane and dried under reduced pressure to give 4.42 g of the desired product as a yellow powder. Yield was 70.0 percent.
[1085] v) Preparation of Dichloro(N-1,1-dimethylethyl)-1,1-(4-butyl-phenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)titanium
[1086] In the drybox, 2.62 g (7.10 mmol) of TiCl3(THF)3was suspended in 40 mL of TBF. To this solution, 4.32 g (7.07 mmol) of dilithium salt of (4-n-Bu-Ph)2Si(3-isoindolino-indenyl)(NH-t-Bu) dissolved in 60 mL of THF was added within 2 minutes. The solution was then stirred for 60 minutes. After this time, 1.28 g of PbCl2(4.60 mmol) was added and the solution was stirred for 60 minutes. The THF was then removed under reduced pressure. The residue was extracted with 50 mL of toluene and filtered. Solvent was removed under reduced pressure leaving a black crystalline solid. Hexane was added (35 mL) and the black suspension was stirred for 0.5 hour. The solids were collected on the frit, washed with 2×30 mL of hexane and dried under reduced pressure to give 4.68 g of the desired product as a black-blue, crystalline solid. Yield was 92.4 percent.
Example 15
Preparation of (N-1,1-Dimethylethyl)-1,1-(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-dimethyltitanium
[1087]
[1088] Dichloro(N-1,1-dimethylethyl)-1,1-(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)titanium (1.61 g, 2.25 mmol, Example 14) was suspended in 35 mL of toluene. To this suspension was added 3 mL (4.75 mmol) of 1.6 M MeLi ether solution. The reaction color changed at once from dark green-black to dark red. After stirring for 1 hour, the solvent was removed under reduced pressure. The residue was extracted with 55 mL of hexane and filtered. Solvent was removed leaving 1.46 g of the desired product as a red solid.
Example 16
Preparation of (N-1,1-Dimethylethyl)-1,1-(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)titanium (II) 1,3-pentadiene
[1089]
[1090] Dichloro(N-1,1-dimethylethyl)-1,1-(4-butyl-phenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)titanium (1.266 g, 1.77 mmol, Example 14) was suspended in 60 mL of hexane. The mixture was brought to gentle reflux and then 0.9 mL (0.89 mmol) of piperylene was added followed by 1.86 mL (3.72 mmol) of BrMgBu (2 M in THF). The reaction mixture was refluxed for 2.5 hour. After cooling to room temperature the solution was filtered and solvent was removed under reduced pressure leaving 1.30 g of the desired product as a black glassy solid.
Example 17
Preparation of (N-(1,1-Dimethylethyl)-1,1-di(4-n-butylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-[(dimethylsilylene)bis(methylene)]titanium
[1091]
[1092] To a 50 mL toluene solution containing 2.33 g, (3.26 mmol) of dichloro(N-(1,1-dimethylethyl)-1,1-di(4-n-butyl-phenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)titanium (Example 14) was added 3.62 g, 4.23 mmol of Me2Si(CH2MgCl)2(THF)9as a solid. After stirring overnight at room temperature, the solution color changed from green-black to red. Solvent was removed under reduced pressure. The residue was extracted with 40 mL of hexane and filtered. The solvent was removed under reduced pressure to give a red glassy solid. This material was dissolved in 40 mL of hexane and filtered thought a fine frit. Solvent removal gave 2.16 g of product as a red glassy solid. Yield was 89.0 percent.
[1093] 1H NMR (C6D6): δ −0.03 (s, 3H), 0.44 (s, 3H), 0.62 (d, 1H, 2JH-H=12.6 Hz), 0.83 (q, 6H, 3JH-H=7.9 Hz), 1.24 (m, 4H), 1.52 (m, 4H), 1.54 (s, 9H), 2.34 (s, 2H), 2.45 (d, 1H, 2JH-H=13.4 Hz), 2.52 (t, 4H, 3JH-H=7.8 Hz), 4.61 (m, 4H), 5.84 (s, 1H), 6.74 (t, 1H, 3JH-H=7.7 Hz), 6.89 (d, 1H, 3H-H=8.7 Hz), 6.94 (m, 2H), 7.05 (m, 2H), 7.15 (d, 2H, 3JH-H=7.5 Hz), 7.26 (d, 2H, 3JH-H=7.8 Hz), 7.31 (d, 1H, 3JH-H=9.0 Hz), 7.57 (d, 1H, 3JH-H=8.7 Hz), 8.13 (d, 2H, 3JH-H=7.8 Hz), 8.17 (d, 2H, 3JH-H=7.8 Hz).
[1094] 13C{1H} NMR (C6D6): δ −1.08, −0.28, 14.11, 14.15, 33.70, 33.78, 35.91, 36.06, 56.63, 56.88, 80.31, 84.35, 85.24, 103.81, 122.61, 122.81, 122.82, 124.27, 124.36, 127.34, 128.47, 128.51, 129.72, 131.03, 134.87, 135.00, 136.66, 137.16, 137.79, 143.36, 144.66, 144.85.
[1095] HRMS (EI): calculated for C39H46N2Si2Ti (M)+0646.2679, found 646.2640.
[1096] Analysis: Calculated for C39H46N2Si2Ti: C, 72.42; H, 7.17; N, 4.33. Found: C, 72.78; H, 7.53; N, 4.13.
[1097] Ethylene/Octene Copolymerization
[1098] The reaction conditions of Runs 1-30 were substantially repeated using toluene solutions of catalyst and cocatalyst, methyl(di(C14-18alkyl)ammonium tetralcis(pentafluorophenyl)borate. Results are contained in Table 2.
| TABLE 2 | |||||||
|---|---|---|---|---|---|---|---|
| Cat./cocat. | C | Yield | Efficiency | Density | |||
| Run | Catalyst | (μmoles) | (g) | (g) | (g/μg Ti) | (g/ml) | MMI |
Example 18
Preparation of (N-1,1-Dimethylethyl)-1,1-(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-bis[(trimethylsilyl)methyl]-titanium
[1099]
[1100] In the drybox 3.42 g of dichloro(N-1,1-dimethylethyl)-1,1-(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)titanium (5.42 mmol) (prepared substantially according to example 5) was partly dissolved in 70 mL of toluene. To this solution 11.6 mL (11.6 mmol) of LiCH2TMS (1 M in pentane) was added dropwise while stirring over a one minute period. After the addition of lithium reagent was completed, the solution was stirred for 15 hours at room temperature. The reaction mixture was filtered and solvent was removed under reduced pressure. The resulting solid was dissolved in 15 mL of toluene followed by addition of 45 mL of hexane. The solution was filtered and solvent removed under reduced pressure leaving a red-brown crystalline solid. Hexane was added (25 mL) and the mixture was stirred for 10 min. and then put into freezer for 24 hours. Red crystalline solid was collected by filtration, washed with 2×8 mL of cold hexane, and then dried under reduced pressure to give 2.722 g of the desired product.
[1101] 1H NMR (C6D6): δ −0.67 (d, 2H, 2JH-H=11.7 Hz, —CH2Si(CH3)3), 0.14 (s, 9H, —CH2Si(CH3)3), 0.20 (s, 9H, —CH2Si(CH3)3), 1.10 (d, 2H, 2JH-H=12.0 Hz, —CH2Si(CH3)3), 1.31 (m, 2H, —CH2Si(CH3)3), 1.71 (s, 9H, C(CH3)3), 2.13 (s, 6H), 4.77 (d, 2H, 2JH-H=12.0 Hz), 4.91 (d, 2H, 2JH-H=12.0 Hz), 5.78 (s, 1H), 6.73 (t, 1H, 3JH-H=7.7 Hz), 6.98 (m, 3H), 7.05 (m, 2H), 7.13 (d, 2H, 3JH-H=7.8 Hz), 7.20 (d, 2H, 3JH-H=7.8 Hz), 7.33 (d, 1H, 3JH-H=8.4 Hz), 7.78 (d, 1H, 3JH-H=9.0 Hz), 7.98 (d, 2H, 3JH-H=7.5 Hz), 8.06 (d, 2H, 3JH-H=7.8 Hz).
[1102] 13C{1H} NMR (C6D6): δ 2.74, 3.52, 21.47, 21.50, 35.33, 57.03, 58.74, 69.08, 80.50, 84.92, 102.34, 122.57, 124.42, 124.78, 124.92, 125.12, 127.55, 128.92, 129.09, 129.49, 133.99, 134.30, 134.60, 136.65, 137.09, 137.43, 139.72, 139.83, 146.11.
[1103] HRMS (EI): calculated for C43H58N2Si3Ti (M)+735.3465, found 735.3461.
[1104] Analysis Calculated for C43H58N2Si3Ti: C, 70.26; H, 7.95; N, 3.81. Found: C, 65.96; H, 8.74; N, 2.11.
[1105] The X-ray structure (ORTEP) for the compound is provided in FIG. 3.
Example 19
Preparation of (N-1,1-Dimethylethyl)-1,1-(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-[(dimethylsilylene)bis(methylene)]titanium
[1106]
[1107] A) Tetramethylsilane[MgCl]2(TBF)6
[1108] To 40 mL diethyl ether solution of 2.5 g, 15.9 mmol of Me2Si(CH2Cl)2was added 0.851 g, 35.0 mmol of Mg turnings. After stirring overnight large amount of white solid was visible. Solvent was removed under reduced pressure and replaced with 40 mL of tetrahydrofuran (THF). Upon addition of THF all of the white solid dissolved. After stirring an additional 24 hr, about 20 mL of hexane was added and the solution was filtered. The filtrate was put into a freezer (−27° C.) overnight. Solvent was decanted and large colorless crystals were washed with cold hexane (2×20 mL). The solid was then dried under reduced pressure to give 2.753 g of product as the THF hexa-adduct. Yield was 27.1 percent.
[1109] 1H NMR (THF-d8): δ −1.81 (s, 4H), −0.21 (s, 6H), 1.77 (m, 28H, THF), 3.66 (m, 28H, THF).
[1110] 13C{1H} NMR (THF-d8): δ −2.50, 9.14, 26.37 (THF), 68.46 (THF).
[1111] B) Preparation of (N-1,1-Dimethylethyl)-1,1-(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)-[(dimethylsilylene)bis-(methylene)] titanium
[1112] To a 50 mL toluene solution containing 0.60 g, 0.95 mmol of dichloro(N-(1,1-dimethylethyl)-1,1-di(4-methyl-phenyl)-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)titanium (prepared substantially according to the technique of Example 5) was added 0.667 g, 1.05 mmol of Me2Si(CH2MgCl)2(THF)6as a solid. After stirring for 2 hours at room temperature, proton NMR analysis showed about 70 percent conversion to the product. After stirring an additional 2 days, the 1H NMR spectrum did not change. An additional 0.25 g of the diGrigniard was added. Within minutes the reaction mixture turned from green-yellow to red. After stirring an additional 6 hours, the solvent was removed under reduced pressure. The residue was extracted with 40 mL of hexane and filtered. Solvent was removed under reduced pressure to give a red glassy solid. This solid was dissolved back in 15 mL of hexane. After standing at room temperature overnight, the solvent was decanted and red crystals were washed with cold hexane (2×2 mL). These crystals were dried under reduced pressure to give 0.448 g of the desired product. Yield was 72.9 percent.
[1113] 1H NMR (C6D6): δ −0.04 (s, 3H), 0.44 (s, 3H), 0.63 (d, 1H, 2JH-H=12.9 Hz), 1.52 (s, 9H), 2.15 (s, 6H), 2.34 (m, 2H), 2.45 (d, 1H, 2JH-H=12.9 Hz), 4.61 (m, 4H), 5.81 (s, 1H), 6.74 (t, 1H, 3JH-H=7.8 Hz), 6.88 (d, 1H, 3JH-H=6.6 Hz), 6.92 (m, 2H), 7.05 (m, 2H), 7.15 (d, 2H, 3JH-H=8.1 Hz), 7.21 (d, 2H, 3JH-H=8.1 Hz), 7.37 (d, 1H, 3JH-H=8.4 Hz), 7.56 (d, 1H, 3JH-H=8.4 Hz), 8.09 (d, 2H, 3JH-H=6.9 Hz), 8.11 (d, 2H, 3JH-H=7.2 Hz).
[1114] 13C{1H} NMR (C6D6): δ −1.10, −0.30, 21.50, 21.56, 35.87, 56.62, 56.88, 80.27, 84.40, 85.15, 103.75, 122.61, 122.81, 123.83, 124.29, 124.37, 127.35, 129.12, 129.68, 130.98, 134.58, 134.61, 136.65, 137.14, 137.78, 139.66, 139.86, 143.33.
[1115] HRMS (EI): calculated for C39H46N2Si2Ti (M)+646.2679, found 646.2640.
[1116] Analysis: Calculated for C39H46N2Si2Ti: C, 72.42; H, 7.17; N, 4.33. Found: C, 72.78; H, 7.53; N, 4.13.
[1117] The X-ray structure (ORTEP) for the compound is provided in FIG. 4.
Example 20
Preparation of Dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium
[1118]
[1119] (A) Preparation of N-(tert-Butyl)-N-(1-chloro-1,1-diphenylylsilyl)amine.
[1120] To a solution of of 12.66 g (50.0 mmol) of dichlorodiphenylsilane in 300 mL of hexane was added 7.38 g (101 mmol) of t-butyl amine. The reaction mixture was stirred overnight, then filtered. The hexane was removed under reduced pressure to give the product as a viscous colorless oil. The yield was 13.55 g (94 percent yield).
[1121] 1H (C6D6) δ: 1.10 (s, 9H), 1.51 (s, 1H), 7.14 (m, 6H), 7.85 (m, 4H). 13C{1H}(C6D6) δ: 33.2, 50.8, 128.22, 130.67, 134.9, 135.81.
[1122] (B) Preparation of N-(tert-Butyl)-N-(1,1-diphenyl-1-(3-tetrahydro-1H-1-pyrrolyl-1H-1-indenyl)silyl)amine.
[1123] A solution of 1-(1H-3-indenyl)pyrrolidine, lithium salt (2.00 g, 10.46 mmol) in 40 mL of THF was added dropwise to a 80 mL THF solution N-(tert-butyl)-N-(1-chloro-1,1-diphenylylsilyl)amine (3.03 g, 10.46 mmol). After the addition was complete the reaction mixture was stirred overnight. The solvent was then removed under reduced pressure. The residue was extracted with hexane and the solution filtered. The solvent was then removed under reduced pressure leaving 4.57 g of product. Yield was 99 percent.
[1124] 1H (CDCl3) δ: 1.17 (s, 9H), 1.83 (m, 4H), 2.85 (m, 2H), 3.20 (m, 2H) 5.25 (s, 1H), 7.00-7.84 (m, 14H). 13C{1H}(CDCl3) δ: 25.03, 33.43, 33.63, 40.39, 46.44, 49.92, 50.53, 104.36, 120.23, 123.28, 124.06, 124.27, 126.91, 127.10, 127.42, 127.69, 128.86, 129.00, 134.97, 135.13, 135.34, 135.50, 141.20, 145.23, 149.59.
[1125] (C) Preparation of N-(tert-Butyl)-N-(1,1-diphenyl-1-(3-tetrahydro-1H-1-pyrrolyl-1H-1-indenyl)silyl)amine, Dilithium Salt.
[1126] In the drybox 4.57 g (10.42 mmol) of N-(tert-butyl)-N-(1,1-diphenyl-1-(3-tetrahydro-1H-1-pyrrolyl-1H-1-indenyl)silyl)amine was combined with 80 mL of hexane. To this solution 13.0 mL (20.83 mmol) of n-BuLi (1.6 M in hexanes) was added dropwise. Upon complete addition of the n-BuLi the solution was stirred overnight. The resulting precipitate was collected via filtration, washed with hexane and dried under reduced pressure to give 3.37 g of product. Yield was 72 percent.
[1127] (D) Preparation of Dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium
[1128] N-(tert-butyl)-N-(1,1-diphenyl-1-(3-tetrahydro-1H-1-pyrrolyl-1H-1-indenyl)silyl)amine, dilithium salt (3.37 g, 7.47 mmol) was added as a solid to a 80 mL solution of THF containing TiCl3(THF)3(2.77 g, 7.47 mmol). After 45 minutes, PbCl2(1.03 g, 3.73 mmol) was added as a solid. The reaction mixture was then stirred an additional hour. The solvent was removed under reduced pressure. The residue was extracted with toluene and filtered. Toluene was removed under reduced pressure and the residue was triturated with hexane. The solid was collected by filtration, washed with hexane and then dried under reduced pressure. 3.39 g of product was obtained (82 percent yield).
[1129] 1H (CDCl3) δ: 1.47 (s, 9H), 2.04 (m, 4H), 3.78 (br, s, 2H), 4.05 (br, s, 2H), 5.80 (s, 1H), 6.95 (m, 1H), 7.05 (m, 1H), 7.21-7.26 (m, 2H), 7.57 (m, 5H), 7.95 (m, 5H), 13C{1H}(CDCl3) δ: 25.71, 33.36, 50.71, 60.78, 93.14, 107.76, 125.63, 126.82, 127.34, 128.13, 128.19, 128.99, 129.24, 130.31, 130.51, 134.66, 134.74, 135.48, 135.99, 136.28, 150.48.
Example 21
Preparation of (N-(1,1-Dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-dimethyl-titanium
[1130]
[1131] To 0.50 g of dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium (0.90 mmol) was added 40 mL of Et2O. To this suspension, 1.12 mL of MeLi (1.6 M in Et2O) was added dropwise with stirring. Upon completion of the addition, of the MeLi the solution was stirred for 30 minutes. After this time period the Et2O was removed under reduced pressure and the residue extracted with hexane, the solution filtered, the filtrate evaporated to dryness under reduced pressure to give 0.31 g of product. Yield was 66 percent.
[1132] 1H (C6D6) δ: 0.14 (s, 3H), 0.87 (s, 3H), 1.32 (bs, 4H), 1.57 (s, 9H), 2.99 (bs, 2H), 3.22 (bs, 2H), 5.44 (s, 1H), 6.75 (t, 1H), 6.95 (t, 1H), 7.02-7.32 (bs, 4H), 7.54 (d, 1H), 7.83 (d, 2H), 8.05 (d, 2H). 13C{1H}(C6D6) δ: 25.81, 35.30, 50.24, 50.43, 55.83, 57.36, 82.73, 105.09, 124.37, 124.86, 125.12, 125.51, 128.32, 128.73, 129.87, 130.03, 133.63, 136.29, 136.65, 137.55, 138.13, 144.96.
Example 22
Preparation of (N-(1,1-Dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)bis(trimethylsilylmethyl)titanium
[1133] In the drybox 0.4 g of dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)titanium complex (Example 1, 0.72 mmol) was dissolved in 30 mL of toluene. To this solution, 1.51 mL (1.51 mmol) of MgClCH2TMS (1 M in ether) was added dropwise while stirring over a 2 minute period. After the addition of Grignard reagent was completed, the solution was stirred for 90 minutes. The solvent was removed under reduced pressure and the residue was extracted with 30 mL of hexane and filtered. Hexane was removed leaving 0.419 g of red solid that was dissolved in about 10 mL of hexane and put into a freezer at −27° C. After two days, the solvent was slowly removed under reduced pressure and then about 4 mL of hexane was added causing only partial dissolution of the solid. The vial was put into a freezer overnight. The solvent was decanted and the dark red crystals were washed with 2 mL of hexane and were dried under reduced pressure to give 124 mg of the desired product.
[1134] 1H (C6D6) δ: −0.69 (d, 1H, 2JH-H=12.0 Hz), 0.15 (s, 9H), 0.29 (s, 9H), 1.07 (d, 1H, 2JH-H=12.0 Hz), 1.23 (s, 2H), 1.50 (m, 4H), 1.67 (s, 9H), 3.33 (m, 2H), 3.43 (m, 2H), 5.61 (s, 1H), 6.68 (t, 1H, 3JH-H=7.7 Hz), 6.96 (t, 1H, 3JH-H=7.7 Hz), 7.20-7.34 (m, 7H), 7.70 (d, 1H, 3JH-H=9.0 Hz), 7.98 (m, 2H), 8.10 (m, 2H)
[1135] 13C{1H}(C6D6) δ: 2.68, 3.59, 25.62, 35.32, 50.70, 58.42, 68.57, 79.80, 83.97, 101.19, 124.16, 125.06, 127.98, 128.17, 129.22, 129.88, 129.98, 134.10, 136.43, 136.88, 137.89, 138.10, 147.38.
Example 23
Preparation of Dichloro(N-(1,1-dimethylethyl)-1,1-di(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)sflanaminato-(2-)-N-)-titanium
[1136]
[1137] (A) Preparation of N-(tert-Butyl)-N-(1-chloro-1,1-di-p-tolylsilyl)amine.
[1138] To a solution of of 10.0 g (35.6 mmol) of dichloro-p-ditolylsilane in 300 mL of hexane was added 5.20 g (71.1 mmol) of t-butyl amine. The reaction mixture was stirred overnight, then filtered. The hexane was removed under reduced pressure to give the product as a viscous, colorless oil. The yield was 10.83 g (96 percent).
[1139] 1H (C6D6) δ: 1.12 (s, 9H), 2.04 (s, 6H), 7.01 (d, 4H), 7.82 (d, 2H). 13C{1H}(C6D6) δ: 21.4, 33.2, 50.80, 129.06, 132.67, 135.09, 140.46.
[1140] (B) Preparation of N-(tert-Butyl)-N-(1,1-di(4-methylphenyl)-1-(3-tetrahydro-1H-1-pyrrolyl-1H-1-indenyl)silyl)amine.
[1141] A solution of 1-(1H-3-indenyl)pyrrolidine, lithium salt (1.00 g, 5.23 mmol) in 40 mL of THF was added dropwise to a 80 mL THF solution N-(tert-butyl)-N-(1-chloro-1,1-di-p-tolylsilyl)amine (1.66 g, 5.23 mmol). After the addition was complete the reaction mixture was stirred overnight. The solvent was then removed under reduced pressure. The residue was extracted with hexane and the solution filtered. The solvent was then removed under reduced pressure leaving 2.41 g of product. Yield was 99 percent.
[1142] 1H(C6D6) δ 1.07 (s, 9H), 1.52 (bs, 4H), 2.04 (s, 3H), 2.09 (s, 3H), 3.00 (bs, 2H), 3.14 (bs, 2H), 4.07 (s, 1H), 5.52 (s, 1H), 7.00-7.84 (m, 12H).
[1143] (C) Preparation of N-(tert-Butyl)-N-(1,1-di(4-methylphenyl)-1-(3-tetrahydro-1H-1-pyrrolyl-1H-1-indenyl)silyl)amine, Dilithium Salt.
[1144] In the drybox, 2.41 g (5.16 mmol) of N-(tert-butyl)-N-(1,1-di(4-methylphenyl)-1-1-(3-tetrahydro-1H-1-pyrrolyl-1H-1-indenyl)silyl)amine was combined with 80 mL of hexane. To this solution, 6.45 mL (10.33 mmol) of n-BuLi (1.6 M in hexanes) was added dropwise. Upon complete addition of the n-BuLi, the solution was stirred overnight. The resulting precipitate was collected via filtration, washed with hexane and dried under reduced pressure to give 1.52 g of product. Yield was 61 percent.
[1145] (D)) Preparation of Dichloro(N-(1,1-dimethylethyl)-1,1-di(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium
[1146] N-(tert-butyl)-N-(1,1-di(4-methylphenyl)-1-(3-tetrahydro-1H-1-pyrrolyl-1H-1-indenyl)silyl)amine, dilithium salt (1.52 g, 3.26 mmol) was added as a solid to a 80 mL solution of THF containing TiCl3(THF)3(1.21 g 3.26 mmol). After 45 min, PbCl2(0.45 g, 1.63 mmol) was added as a solid. The reaction mixture was then stirred an additional hour. The solvent was removed under reduced pressure. The residue was extracted with toluene and filtered. Toluene was removed under reduced pressure and the residue was triturated with hexane. The solid was collected by filtration, washed with hexane and then dried under reduced pressure. 1.40 g of product was obtained. Yield was 73 percent.
[1147] 1H (CDCl3) δ 1.33 (s, 9H), 1.99 (br s, 4H), 2.36 (s, 3H), 2.39 (s 3H), 3.65 (br s, 2H), 3.87 (br s, 2H), 5.74 (s, 1H), 7.10 (m, 1H), 7.25 (bs, 5H), 7.60 (m, 2H), 7.77 (s, 2H) 7.82 (d, 1H).
[1148] 13C{1H}(CDCl3) δ: 21.01, 21.68, 25.73, 333.35, 50.70, 60.86, 83.69, 107.91, 125.58, 126.81, 127.23, 127.98, 128.95, 128.99, 129.37, 131.23, 135.48, 136.08, 136.36, 140.33, 140.53, 150.38.
Example 24
Preparation of (N-(1,1-Dimethylethyl)-1,1-di(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)sflanaminato-(2-)-N-)dimethyltitanium
[1149]
[1150] In the drybox 0.444 g dichloro(N-(1,1-dimethylethyl)-1,1-di(4-methylphenyl)-1-((1,2,3,3a,7a-η)-3-(1-pyrrolidinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)titanium complex (0.76 mmol) was dissolved in 30 mL of diethylether. To this solution 1.00 mL (1.6 mmol) of MeLi (1.6 M in ether) was added dropwise while stirring over a 2 minute period. After the addition of MeLi was completed, the solution was stirred for 1.5 hour. Et2O was removed under reduced pressure and the residue extracted with 45 mL of hexane. Hexane was removed under reduced pressure giving 0.348 mg of red, crystalline material. This red solid was dissolved in about 5 mL of hexane (heating was used) and then the vial was put into freezer overnight at −27° C., giving 75 mg of red crystals.
[1151] 1H (C6D6) δ: 0.26 (s, 3H), 1.01 (s, 3H), 1.44 (m, 4H), 1.72 (s, 9H), 2.01 (s, 3H), 2.14 (s, 3H), 3.12 (m, 2H), 3.36 (m, 2H), 5.60 (s, 1H), 6.70 (ddd, 1H, 3JH-H=8.7 Hz, 3JH-H=6.6 Hz, 4JH-H=0.9 Hz), 6.96 (ddd, 1H, 3JH-H=8.6 Hz, 3JH-H=6.6 Hz, 4JH-H=0.9 Hz), 7.12 (m, 4H), 7.68 (d, 1H, 3JH-H=8.7 Hz), 7.68 (d, 1H, 3JH-H=9.0 Hz), 7.89 (d, 2H, 3JH-H=7.8 Hz), 8.11 (d, 2H, 3JH-H=7.8 Hz).
[1152] 13C{1H} (C6D6) δ: 21.43, 21.50, 25.82, 35.31, 49.87, 50.45, 55.53, 57.45, 83.28, 105.28, 124.31, 124.86, 125.00, 125.50, 128.86, 128.96, 129.20, 133.65, 134.08, 134.77, 136.46, 136.81, 139.57, 139.76, 144.86.
[1153] Ethylene 1-Octene Copolymerizations
[1154] The reaction conditions of Runs 1-33 were substantially repeated. Metal complex as a dilute toluene solution and cocatalyst as dilute solutions in toluene or methylcyclohexane, were mixed in a 1:1 molar ratio and transferred to a catalyst addition tank and injected into the reactor. The cocatalyst for all runs was methyldi(octadecyl)ammonium tetrakis(pentafluorophenyl)borate. Results are contained in Table 3.
| TABLE 3 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Catalyst | Temp. | Yield | Density | Mw | ||||
| Run | (μmol) | (° C.) | (g) | Eff. | (g/ml) | (×10 | Mw/Mn | MMI |
Example 25
Preparation of [1-[(1,2,2a,10b,11-η)-1H-Cyclopenta[l]phenanthren-2-yl]-N-(1,1-dimethylethyl)-1,1-dimethylsilanaminato(2-)-N]-bis[(trimethylsilyl)methyl]-titanium
[1155]
[1156] In the drybox 1.893 g of dichloro[1-[(1,2,3,3a,11b-η)-1H-cyclopenta[l]phenanthren-2-yl]-N-(1,1-dimethylethyl)-1,1-dimethylsilanaminato(2-)-N]-titanium (4.09 mmol) (prepared according to EP-A-1,017,701, U.S. Ser. No. 09/122958, filed Jul. 27, 1998) was partly dissolved in 45 mL of toluene. To this solution 8.4 mL (8.4 mmol) of lithiumtrimethylsilylmethyl (LiCH2TMS) (1M solution pentane) was added over a 1 minute period while stirring. After addition, the reaction mixture was stirred for 2 hours and the solvent was removed under reduced pressure. The yellow residue was extracted with 40 mL of hot hexane and filtered. The solution was cooled to room temperature (crystals started to form) and put into the freezer (−27° C.) for 18 hours. Solvent was decanted and the large yellow crystals were washed with cold hexane (2×10 mL) and then dried under reduced pressure to give 1.82 g of the desired product. Yield was 67.5 percent. The single crystal X-ray structure (ORTEP) of the complex was obtained and is reproduced as FIG. 5 attached hereto.
[1157] 1H NMR (C7D8): δ −0.19 (s, 18H, —CH2Si(CH3)3), 0.50 (s, 6H, —Si(CH3)2), 0.78 (d, 2H, 2JH-H=10.8 Hz, —CH2Si(CH3)3), 0.94 (d, 2H, 2JH-H=10.8 Hz, —CH2Si(CH3)3), 1.55 (s, 9H, —C(CH3)3), 6.71 (s, 2H), 7.33 (td, 2H, 3JH-H=6.9 Hz, 4JH-H=1.5 Hz), 7.39 (td, 2H, 3JH-H=6.9 Hz, 4JH-H=1.2 Hz), 7.98 (dm, 2H, 3JH-H=7.8 Hz), 8.24 (dm, 2H, 3JH-H=8.1 Hz).
[1158] 13C (gated coupled) NMR (C7D8): δ 1.34 (q, 1JC-H=120.0 Hz, —Si(CH3)2), 2.59 (q, 1JC-H=118.0 Hz, —CH2Si(CH3)3), 34.04 (q, 1JC-H=125.1 Hz, —C(CH3)3), 60.87 (s, —C(CH3)3), 76.89 (t, 1JC-H=106.8 Hz, —CH2Si(CH3)3), 108.70 (s), 112.11 (dd, 1JC-H=171.2 Hz, JC-H=9.1 Hz), 124.11 (dd, 1JC-H=155.6 Hz, 3JC-H=7.0 Hz), 125.83 (dd, 1JC-H=157.7 Hz, 3JC-H=6.6 Hz), 127.49 (dd, 1JC-H=160.2 Hz, 3JC-H=8.1 Hz), 128.36, 130.31 (m), 130.87 (m).
[1159] HRMS (EI): calculated for C30H44NSi3Ti (M—CH3)+550.2261, found 550.2252.
[1160] Analysis Calculated for C31H47NSi3Ti: C, 65.80; H, 8.37; N, 2.48. Found: C, 65.96; H, 8.74; N, 2.11.
Example 26
Preparation of [1-[(1,2,2a,10b,11-η)-1H-Cyclopenta[l]phenanthren-2-yl]-N-(1,1-dimethylethyl)-1,1-dimethylsilanaminato(2-)-N]-[(dimethylsilylene)-bis(methylene)] titanium
[1161]
[1162] To a 50 mL toluene suspension containing 0.624 g, 1.35 mmol of dichloro[1-[(1,2,3,3a,11b-η)-1H-cyclopenta[l]phenanthren-2-yl]-N-(1,1-dimethylethyl)-1,1-dimethylsilanaminato(2-)-N]-titanium derivative was added 1.294 g, 2.03 mmol of Me2Si(CH2MgCl)2(THF)6as solid crystals. After stirring overnight solvent was removed under reduced pressure. The residue was extracted with 40 mL of hot hexane and filtered. The solution was put into a freezer overnight. Solvent was decanted and yellow crystals were washed with 5 mL of cold hexane and then dried under reduced pressure to give 350 mg of product. The solution was decanted and volatiles removed under reduced pressure and the remaining solid was dissolved hot in 5 mL of hexane and filtered. The solution was then put into freezer overnight. The precipitated solid was washed with cold hexane and dried under reduced pressure to give 165 mg of product. Combined yield was 515 mg, 57.8 percent.
[1163] 1H NMR (C6D6): δ −1.27 (s, 3H), 0.19 (s, 3H), 0.56 (s, 6H), 1.33 (s, 9H), 1.81 (d, 2H, 2JH-H=13.8 Hz), 2.37 (d, 2H, 2JH-H=13.5 Hz), 6.89 (s, 1H), 7.31 (m, 4H), 7.89 (m, 2H), 8.21 (m, 2H).
[1164] 13C{1H} NMR (C6D6): δ −3.68, −1.08, 1.39, 35.06, 58.45, 84.45, 109.15, 111.07, 123.91, 125.23, 127.16, 127.64, 128.51, 128.59, 130.52.
[1165] HRMS (EI): calculated for C27H35Si2NTi (M)+477.1787, found 477.1792.
[1166] Analysis: Calculated for C27H35Si2NTi: C, 67.90; H, 7.39; N, 2.93 Found: C, 67.89; H, 7.64; N, 2.52.
Example 27
Preparation of (N-(1,1-Dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,8a-eta)-1,5,6,7-tetrahydro-2-methyl-s-indacen-1-yl)silanaminato(2-)-N)-bis[(trimethylsilyl)methyl]-titanium
[1167]
[1168] In the drybox, 0.710 g of dichloro(N-(1,1-dimetbylethyl)-1,1-dimethyl-1-((1,2,3,3a,8a-eta)-1,5,6,7-tetrahydro-2-methyl-s-indacen-1-yl)silanaminato(2-)-N)-titanium (prepared according to U.S. Pat. No. 5,965,756) (1.71 mmol) was partly dissolved in 20 mL of toluene. To this solution, 3.6 mL (3.58 mmol) of LiCH2TMS (1 M in pentane) was added dropwise while stirring over a one minute period. Solution color changed at once from red to yellow. After the addition of lithium reagent was complete, the solution was stirred for 1 hour. The solution was filtered and solvent was removed under reduced pressure leaving yellow, crystalline solid. The resulting solid was dissolved in 20 mL of hexane and solution was filtered. The solution was put aside into a freezer overnight. The solvent was decanted and large yellow crystals were washed with 2×10 mL of cold hexane and then dried under reduced pressure to give 565 mg of product. Yield was 63.7 percent.
[1169] 1H NMR (C6D6): δ −0.78 (d, 2H, 2JH-H=11.4 Hz, —CH2Si(CH3)3), 0.03 (s, 9H, —CH2Si(CH3)3), 0.23 (s, 9H, —CH2Si(CH3)3), 0.52 (s, 3H, —Si(CH3)2), 0.66 (d, 2H, 2JH-H=11.7 Hz, —CH2Si(CH3)3), 0.67 (s, 3H, —Si(CH3)2), 1.29 (d, 2H, 2JH-H=11.1 Hz, —CH2Si(CH3)3), 1.42 (d, 2H, 2JH-H=11.1 Hz, —CH2Si(CH3)3), 1.47 (s, 9H, C(CH3)3), 1.85 (m, 2H), 2.10 (s, 3H), 2.73 (m, 2H), 2.82 (m 2H), 6.94, 7.40, 7.49.
[1170] 13C {1H} NMR (C6D6): δ 2.93, 3.18, 6.25, 6.50, 19.29,26.50, 32.71, 32.77, 34.08, 58.39, 71.84, 78.85, 89.82, 113.26, 119.53, 122.11, 131.45, 134.65, 140.95, 143.47, 144.01.
[1171] HRMS (EI): calculated for C27H49NSi3Ti (M)+519.2652, found 519.2616.
[1172] Analysis Calculated for C27H49NSi3Ti: C, 62.39; H, 9.50; N, 2.69. Found: C, 62.46; H, 9.84; N, 3.82.
Example 28
Preparation of (N-(1,1-Dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,8a-eta)-1,5,6,7-tetrahydro-2-methyl-s-indacen-1-yl)silanaminato(2-)-N)-[(dimethylsilylene)bis(methylene)] titanium
[1173]
[1174] In the drybox 0.632 g of dichloro(N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,8a-eta)-1,5,6,7-tetrahydro-2-methyl-s-indacen-1-yl)silanaminato(2-)-N)-titanium (1.52 mmol) was dissolved in 30 mL of toluene. To this solution 0.538 g (1.67 mmol) of Me2Si(CH2MgCl)2(THF)2was added as a solid. After stirring the solution for 15 hours, the solvent was removed under reduced pressure. The resulting solid was dissolved in 35 mL of hexane and filtered. The solution was put into freezer for 2 days. Solvent was decanted and yellow crystals were washed with cold hexane. The solid was dried under reduced pressure to give 0.357 g of product. Yield was 54.5 percent.
[1175] 1H NMR (C6D6): δ 0.14 (s, 3H), 0.42 (s, 3H), 0.50 (dm, 1H, 2JH-H=12.9 Hz), 0.59 (s, 3H), 0.77 (s, 3H), 1.31 (s, 9H), 1.76 (p, 3JH-H=7.2 Hz), 2.00 (d, 1H, 2JH-H=11.9 Hz), 2.03 (d, 1H, 2JH-H=11.9 Hz), 2.03 (d, 1H, 2JH-H=12.6 Hz), 2.17 (s, 3H), 2.62 (m, 2H), 2.72 (m, 2H), 2.89 (dm, 1H, 2JH-H=12.9 Hz), 6.39 (s, 1H), 7.18 (s, 1H), 7.65 (s, 1H).
[1176] 13C{1H} NMR (C6D6): δ−0.71, 0.03, 6.15, 6.81, 18.72, 26.71, 32.52, 32.79, 34.93, 56.43, 78.08, 84.96, 90.50, 114.43, 119.12, 121.79, 130.25, 132.78, 138.81, 142.86, 143.38.
Example 29
Preparation of (Tetramethylcyclopentadienyl)-N-(1,1-dimethylethyl)-1,1-dimethylsflanaminato(2-)-N]-bis[(trimethylsilyl)methyl]-titanium
[1177]
[1178] In the drybox, 1.500 g of dichloro(tetramethylcyclopentadienyl)-N-(1,1-dimethylethyl)-1,1-dimethylsilanaminato(2-)-N]-titanium (4.07 mmol) was partly dissolved in 30 mL of hexane. To this mixture 8.4 mL (8.4 mmol) of LiCH2TMS (1 M in pentane) was added dropwise while stirring over a 1 minute period. After the addition of the lithium reagent was completed, the solution was stirred for 2 hours. The solvent was removed under reduced pressure leaving a yellow-green crystalline solid. The solid was dissolved in 30 mL of hexane and the solution was filtered. Solvent was removed under reduced pressure leaving 1.47 g of the desired product as a yellow solid.
[1179] 1H NMR (C6D6): δ 0.19 (s, 18H), 0.46 (s, 6H), 0.93 (s, 4H), 1.52 (s, 9H), 1.94 (s, 6H), 2.03 (s, 6H).
[1180] 13C{1H} NMR (C6D6): δ 3.10, 6.44, 12.67, 15.86, 33.88, 58.58, 72.08, 98.74, 129.29, 132.98.
[1181] HRMS (EI): calculated for C23H49NSi3Ti (M—CH3)+456.2418, found 456.2418.
[1182] Analysis Calculated for C23H48NSi3Ti: C, 58.68; H, 10.28; N, 2.98. Found: C, 58.71; H, 10.47; N, 3.04.
[1183] Ethylene/Styrene Copolymerization
[1184] The reaction conditions of the previous polymerization were substantially repeated excepting that styrene (445 g) was used in place of 1-octene. Toluene (445 g) was used in place of mixed hexanes, ethylene was added under a pressure of 200 psig (1.4 MPa), the hydrogen differential pressure was 50 psig (0.4 MPa), the reactor temperature was set at 90° C., and the reaction time was 30 minutes. The cocatalyst for all runs was methyldi(octadecyl)ammonium tetrakis(pentafluoro-phenyl)borate. Results are contained in Table 4.
| TABLE 4 | |||||||
|---|---|---|---|---|---|---|---|
| Cat./cocat. | C | Yield | Efficiency | Density | |||
| Run | Catalyst | (μmoles) | (g) | (g) | (g/μg Ti) | (g/ml) | MMI |
Claims
What is claimed is:
1. A metal complex corresponding to the formula:
where M is a Group 4 metal that is in the +2, +3 or +4 formal oxidation state;
RAindependently each occurrence is hydrogen, or a hydrocarbyl, halohydrocarbyl, hydrocarbyloxyhydrocarbyl, dihydrocarbylaminohydrocarbyl, dihydrocarbylamino, hydrocarbyloxy, hydrocarbylsilyl, or trihydrocarbylsilylhydrocarbyl group of from 1 to 80 atoms, not counting hydrogen, or two or more RAgroups from the same or different metal complexes or RAand RB′ from the same or different metal complexes are covalently linked together;
Z is a divalent moiety, bound to M via a covalent or coordinate covalent bond, comprising boron, or a member of Group 14 of the Periodic Table of the Elements, and also comprising nitrogen, phosphorus, sulfur or oxygen;
X is an anionic or dianionic ligand group having up to 60 atoms exclusive of the class of ligands that are cyclic, delocalized, π-bound ligand groups;
X′ independently each occurrence is a neutral ligand having up to 40 atoms;
p is zero, 1 or 2, and is two less than the formal oxidation state of M when X is an anionic ligand, and when X is a dianionic ligand group, p is 1;
q is zero, 1 or 2; and
RB′ corresponds to the formula N(RB)2, wherein two RBgroups together form a divalent hydrocarbon moiety or a halo- or silyl-substituted derivative thereof, said group containing from 4 to 40 atoms not counting hydrogen, and comprising at least one fused or unfused aromatic substituent, AR.
2. A metal complex according to claim 1, wherein two RBgroups together with the nitrogen atom form a cycloaliphatic group, and at least one of the ARgroups comprising RBis a single or multiple ring, aromatic group.
3. A metal complex according to claim 1, wherein —N(RB)2is in the form of a multiple ring, fused, aza-cyclic group.
4. A metal complex according to claim 1, wherein 13 N(RB)2is 1,3-dihydro-2H-isoindol-2-yl, 1,2,3,4-tetrahydro-2H-isoquinoline-2-yl, 1,3-dihydro-2H-benzo[f]isoindol-2-yl, 1,3-dihydro-2H-benzo[e]isoindol-2-yl, 1,2,3,4-tetrahydro-2H-benzo[g]isoquinoline-2-yl, 1,2,3,4-tetrahydro-2H-benzo[f]isoquinoline-2-yl, 1,2,3,4-tetrahydro-2H-benzo[h]isoquinoline-2-yl, or 1H-benzo[de]isoquinolin-2(3H)-yl.
5. A metal complex according to claim 1 corresponding to the formula:
where RHis methyl or phenyl;
RIis chloro, methyl, trimethylsilylmethyl or two R1groups together are dimethylsilylene-bis(methylene); and
RJis allyl, 2-(dimethylamino)benzyl, 1,4-pentadiene or 1,4-diphenyl-1,3-butadiene.
6. A metal complex according to claim 1 selected from the group consisting of:
dichloro(N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-1H-inden-1-yl)silanaminato-(2-)-N-)titanium,
(N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)dimethyltitanium,
dichloro(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)titanium,
(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)dimethyltitanium,
dichloro(N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium,
(N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-dimethyl titanium,
dichloro(N-(1,1-dimethyltthyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(3,4-dihydro-2-(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)-titanium,
(N-(1,1-direthylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-(2-)-N-)dimethyl titanium,
(N-(1,1-dimethylethyl)-1,1-dimethyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)bis(trimethylsilylmethyl)titanium,
(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(1,3-dihydro-2H-isoindol-2-yl)-1H-inden-1-yl)silanaminato-(2-)-N-)bis(trimethylsilylmethyl)titanium, and
(N-(1,1-dimethylethyl)-1,1-diphenyl-1-((1,2,3,3a,7a-η)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-1H-inden-1-yl)silanaminato-2-)-N-)bis(trimethylsilylmethyl)titanium.
7. A metal complex corresponding to the formula:
where M is a Group 4 metal that is in the +2, +3 or +4 formal oxidation state;
RAindependently each occurrence is hydrogen, or a hydrocarbyl, halohydrocarbyl, hydrocarbyloxyhydrocarbyl, dihydrocarbylaminohydrocarbyl, dihydrocarbylamino, hydrocarbyloxy, hydrocarbylsilyl, or trihydrocarbylsilylhydrocarbyl group of from 1 to 80 atoms, not counting hydrogen, or two or more RAgroups from the same or different metal complex may be covalently linked together;
two RBgroups together with nitrogen form a cycloaliphatic group having a single C6-20aromatic hydrocarbon group, AR, fused thereto;
Z is a divalent moiety, bound to M via a covalent or coordinate covalent bond, comprising boron, or a member of Group 14 of the Periodic Table of the Elements, and also comprising nitrogen, phosphorus, sulfur or oxygen;
X is an anionic or dianionic ligand group having up to 60 atoms exclusive of the class of ligands that are cyclic, delocalized, π-bound ligand groups;
X′ independently each occurrence is a neutral ligand having up to 40 atoms;
p is zero, 1 or 2, and is two less than the formal oxidation state of M when X is an anionic ligand, and when X is a dianionic ligand group, p is 1; and
q is zero, 1 or 2.
8. A metal complex according to claim 7, wherein the ARgroup comprising RBis a multiple ring, aromatic group.
9. A metal complex according to claim 7, wherein —N(RB)2is in the form of a multiple ring, fused, aza-cyclic group.
10. A metal complex according to claim 9, wherein —N(RB)2is 1,3-dihydro-2H-isoindol-2-yl, 1,2,3,4-tetrahydro-2H-isoquinoline-2-yl, 1,3-dihydro-2H-benzo[f]isoindol-2-yl, 1,3-dihydro-2H-benzo[e]isoindol-2-yl, 1,2,3,4-tetrahydro-2H-benzo[g]isoquinoline-2-yl, 1,2,3,4-tetrahydro-2H-benzo[f]isoquinoline-2-yl, 1,2,3,4-tetrahydro-2H-benzo[h]isoquinoline-2-yl, or 1H-benzo[de]isoquinolin-2(3H)-yl.
11. A metal complex according to claim 7, wherein:
RAindependently each occurrence is —NRB2, hydrogen, or an alkyl, aryl or aralkyl group of up to 10 carbons, and
Y is —NRE— where REis C1-6alkyl or cycloalkyl.
12. A metal complex according to claim 7, wherein (RB)2is N-isoindolyl.
Patent Citations (10)
| Patent | Date | Inventor | Cited By |
|---|---|---|---|
| US5659054(A) | 1997-08-01 | Wilson | Examiner |
| US5965756(A) | 1999-10-01 | McAdon et al. | Examiner |
| US6150297(A) | 2000-11-01 | Campbell et al. | Examiner |
| US6235917(B1) | 2001-05-01 | Graf et al. | Examiner |
| US6245868(B1) | 2001-06-01 | Agapiou et al. | Examiner |
| US6248912(B1) | 2001-06-01 | Lang et al. | Examiner |
| US6268444(B1) | 2001-07-01 | Klosin et al. | Examiner |
| WO98/06728 | 1998-02-01 | Examiner | |
| WO/66596 | 2000-11-01 | Examiner | |
| WO/69870 | 2000-11-01 | Examiner |